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Within a host, pathogenic bacteria employ several mechanisms that enhance their survival 
and motility. These mechanisms include their ability to adhere, replicate (in order to avoid 
eradication), and secretion of virulent proteins. The study of proteins involved in bacterial 
pathogenesis provides us with a more thorough understanding of their mechanism and function, 
which can lead to the development of more effective therapeutics. In this study proteins secreted 
by gram-negative bacteria are explored, specifically those from Pseudomonas aeruginosa and 
Helicobacter pylori. P. aeruginosa is a common opportunistic pathogen associated with 10% of 
hospital infections, mainly owed to their ability to bind to biotic and abiotic surfaces. Type IV pili 
secreted by P. aeruginosa are associated with adhesion, motility and DNA transfer. Part I details 
the cloning to crystallization of KB7, a pilin secreted by P. aeruginosa. The second bacteria studied 
in Part II is H. pylori, associated with gastric ulcers and gastric inflammation compromising 50% 
of the global population, where severity of infection is highly dependent on the strain of H. pylori, 
and the individual infected. The secreted protein HP0175 from H. pylori binds to Toll-Like 
Receptor 4 and activates a cascade of mechanisms leading to apoptosis, as well as triggering the 
innate immune response. HP0175 is also classified as a peptidyl-prolyl cis,trans-isomerase 
involved in the isomerization of proline peptide bonds preceding the N-terminal. Here, apo-
HP0175 was crystallized to 2.09 Å in space group P3221 with one monomer in the asymmetric 
unit; the dimer is generated through symmetry mates. A comparison to indole-2-carboxylic acid 
bound HP0175 shows N- and C- terminal helix extensions upon interaction of the catalytic residues 
in the binding pocket. Helix extension supports other parvulin findings that N- and C- terminal 
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Chapter 1 : Introduction 
1.1. Infections Caused by Pathogenic Bacteria  
The continuous study of microorganisms is often driven due to their pathogenesis, which 
can affect the health of humans, animals, and plants. This complex phenomenon carried by 
bacterial system proteins, begins with adhesion to mucosal surfaces and is commonly observed in 
respiratory, gastrointestinal, and genitourinary tracts.1 For successful colonization of the host, 
bacteria must overcome both non-specific and specific host defense mechanisms such as sneezing, 
coughing, cellular apoptosis, as well as avoid recognition by the immune system.1 Bacteria are 
capable of colonization through distinct mechanisms, including adhesion to epithelial cells using 
various fimbrial proteins, replication (to avoid eradication), and secretion of various virulent 
proteins that can cause disease. 
 
1.2. Bacterial Pili  
Bacterial membranes harbor interesting “nano-machines” that aid in movement and biofilm 
formation.2 Flagella are involved in movement and motility, while pili affect micro-colonization,3 
biofilm formation,4 cell signalling,5 cell-host adhesion,6 DNA uptake by natural transformation,7 
phage attachment,8,9 and twitching motility.10 Pili are a diverse class of proteins often found in 
gram-negative bacteria (such as Pseudomonas aeruginosa), as well as several gram-positive 
bacteria (such as Bacillus subtilis).11 Structural and functional studies of pili provide insight on the 
formation of infection at the molecular level.11 Extensive studies of pili has led to their 
classification based on their assembly in gram-negative bacteria (Figure 1.1). Examples of highly 
studied pili classes include: the chaperone-usher pathway (Type I pili), nucleation-dependent 
polymerization (curli),12 and the type II secretion system (Type IV pili).11–13  
Type I pili are linear, unbranched polymers, composed of pilin subunits that range from 12 
kDa to 20 kDa in size. Their assembly is mediated by the chaperone-usher pathway of pilus 
biogenesis, where the chaperone directs pilus assembly to be secreted through the usher pore.14 
Several type I pili are also involved with specific host attachment and evasion.15 Curli contain a 
coiled-coil structure that can be viewed by electron microscopy. Involved in bacterial aggregation, 
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Curli are able to withstand harsh environments such as 90% formic acid and high temperatures.16,6 
Type IV pili contain similar structural characteristics, with a mode of secretion related to the type 
II system. However, in comparison to other systems, structural and functional studies are highly 
sought after in type IV pili, due to their DNA transformation capability.12 
 
 
Figure 1.1. A structural comparison of gram-negative bacterial pili. The chaperone-usher pili 
(type I) and Curli contain simple systems that span the outer membrane. Chaperone-usher pili 
denoted by the PapA polymer is assembled as a right-handed “one-start” helix. The tip known as 
the PapG pilin contains adhesive properties that is linked to the homopolymer via PapF and PapE. 
Curli filaments are assembled through edge-to-edge aggregation of CsgA and CsgB, secreted by 
the CsgG outer membrane pore. Type IV pili is comprised of a complex system that spans from 
the cytoplasm to the outer membrane. Assembly and disassembly of pilin monomers is driven by 
an ATPase pump that extends from the inner membrane (PilF/PilT). PilQ/PilP are involved in the 
transportation and stabilization of PilE monomers through the outer membrane. Figure adapted 




1.2.1. Type IV Pili Structural Characteristics  
Type IV pili are polymers composed of monomeric pilin subunits that share a distinctive 
architecture (Figure 1.2) with an N-terminal 𝛼-helix, C-terminal globular head domain, ab-loop, 
and a disulfide bounded region (D-region). Moreover, these pili are further classified as type IVa 
and type IVb, which is determined primarily by their amino acid sequence. Type IVb pili remain 
commonly associated with bacteria that colonize human intestines such as Escherichia coli and 
Salmonella enterica serovar typhi. Their composition includes a leader peptide sequence of 15-30 
amino acids, 190 amino acids of mature protein, a 55-amino acid D-region, and a variable N-
terminal methylated residue of methionine, leucine or valine.9 By contrast, type IVa pili possess a 
broad range of targets including mammals, plants, fungi, as well as other bacteria such as P. 
aeruginosa, Shewanella spp., and Geobacter spp.17 Overall, type IVa pili possess shorter peptide 
sequences with a leader sequence of 5-6 amino acids, mature proteins composed of 150 amino 
acids, a D-region that on average spans 22 residues, and interestingly the N-methylated N-terminal 
residue is phenylalanine.  
Crystallization of a native pilin is challenging due to the hydrophobic nature of the a-
helical N-terminal domain, as well their tendency to form fibers exceeds the rate of 
crystallization.18 To date, only two full-length pilin proteins have been characterized by X-ray 
crystallography. Comparison of the N-terminal α-helix was achieved through crystallization of 
full-length gonococcal (GC) pilin from Neisseria gonorrhoeae (MS11 strain)19 and the P. 
aeruginosa strain K (PAK) pilin.20 Comparison of these two structures lead to the observation that 
the N-terminal 𝛼-helical domains behave similarly.18 Truncation of the N-terminal helix aids in 
pilin solubilization, thus full-length and truncated PAK structures were compared. Removal of 28 
amino acids (D1-28) had no effect on the folding of the globular head domain with a root-mean-
square deviation (RMSD) of 0.69 Å for all atoms.19 The N-terminal a-helix domain (residues 1-
52) is generally 80 Å length and contains a slight curvature (kink), caused by a proline residue at 
position 22 both PAK and GC pilins. A second kink is observed in residue 42, occupied by a 
proline in PAK pilin and a glycine in the GC pilin.18,19 The kinks are thought to contribute to fiber 
flexibility, and may reduce inter-subunit packing, which subsequently plays a role in fiber 
assembly and disassembly.17 In comparison to the a-helix in type IVa pili, the a-helix of type IVb 
pili does not contain the same kinks generated by Pro22 and Gly42. The structure of type IVb pili 
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is hypothesized to be less curved, and therefore more flexible due to the lack of this constraint. In 
addition, the N-terminal a-helix is not required for protein oligomerization, observed in studies of 
truncated P. aeruginosa strain K122-4 (D1-28 a.a) pili.21–23  
 
       
Figure 1.2. Schematic representation of a type IV pilin. The full-length PAK pilin structure 
highlights the N-terminal α-helix that extends to the C-terminal region (green). The D-region 
(pink) binds to steel and cell surfaces for motility. Upon packing, the D-region is generally 
conserved except at the tip of the pilus. The helical polymer contains 4-5 subunits per turn, 40 Å 
pitch, and is 6 nm in length. Figure adapted from PDB entry 1OQW.18 
 
1.2.2. Type IV Pili Fibers 
Type IV pili fibers are assembled at a rate of 1000-2000 subunits/s and are able to withstand 
forces greater than 100 pN.24,25 Stabilization of pilus assembly is achieved through the 𝛼-helical 
N-terminal region, through hydrophobic and subunit-subunit interactions.17 Assembly of the pilus 
can be characterized by the axial rise of the fiber, as well as the progression of protein addition 










right handed 1-start, 2) left handed 3-start or 3) a right handed 4-start helical assembly. The 
smallest axial rise represents a right-handed 1-start symmetry, where n represents the first protein, 
n+1 the second, and n+2 the third. In the left-handed 3-start helical symmetry, subunits along the 
axial position are n, n+3, n+6 and so forth (Figure 1.3A and 1.3B). The last representation is the 
right-handed 4-start assembly of proteins n, n+4, n+8, etc. The kinks provided by Pro22 and Gly42 
in the 𝛼-helix influences the formation of an “S shape” that aids in the close packing of the 
polymer.27  
Interactions of type IVa pili within the C-terminal globular head domain are facilitated by 
subunit-subunit interactions, which are primarily found in the loop regions. Further analysis into 
interactions within the C-terminal region displays polar interactions between the 𝛼𝛽-loop and the 
D-region of the next subunit, and interactions proceed between loop regions connecting 𝛽-strands 
in the 3-start and 4-start helical views, respectively.17 Type IVa pili possess a diameter of 60 Å in 
comparison to type IVb pili that have larger diameters of up to 90 Å. The larger diameter in type 
IVb pili is associated with decreased interactions within the C-terminal region, which is only 
facilitated by polar and hydrophobic interactions between 𝛼𝛽-loop, 𝛼3, and parts of the N-terminal 
domain.19,28 The looser packing has been hypothesized to decrease fiber resilience within 
temperature, harsh environments, and proteases when compared to type IVa pili (Figure 1.3C).17   
The pathogenic gram-negative P. aeruginosa has been implicated in infections such as 
ventilator associated pneumonia.29,30 Type IV pili secreted by P. aeruginosa can bind to biotic and 
abiotic surfaces, allowing it to be successful for targeting immune-compromised hospital 
patients.31 Specifically, these infections can occur with cancer,32 cystic fibrosis,33 and human 
immunodeficiency virus (HIV) patients.34 The primary mode of contact for infection begins with 
type IV pili, which has been observed to enhance the pathogen virulence. Further analysis into 
type IV pili binding to cell surface receptors demonstrated that pilus interaction is only achieved 
at the surface monomer through the D-region. The D-region recognizes asialo-
gangliotetraosylceramide; GM1 and GM2 cell surface receptors, specifically the disaccharide 𝛽-D-





Figure 1.3. X-ray and cryo-electron microscopy representation of a T4P assembly. (A) 
Assembly of T4P in a right handed 1-start helical view (outlined by a black arrow). Left handed 
3-start helical view (outlined by a white arrow). (B) Right handed 4-start helical view (outlined by 
a red arrow). Adapted from Baker et al.,2013.26 (C) The T4a pilus is held together through tight 
interactions between N-terminal α-helix within the core. The T4b pilus model shows a bulkier 
assembly in comparison to T4aP, as C-termini head groups are more loosely packed. The closer 
packing of the T4a pilus (60 Å) can be attributed to its apparent resistance to heat, chaotropic 
agents and proteases. Adapted from Giltner et al., 2012.17 
 
1.2.3. In vivo Assembly of Type IV Pili Fibers 
Interestingly, bacteria containing type IV pili are able to alter their sequence while 
maintaining their characteristic pili structure.22 Presence of the same overall structure of the pilin 
monomer allows for the assembly and disassembly of pili through a type II secretion system, 
regardless of sequence diversity. The working model for assembly and disassembly is based on 
studies with N. gonorrhoeae bacteria associated with sexually transmitted infections.28 A general 
mechanism, suggested by Craig et al. in 2006,28 demonstrated the addition of pilin subunits within 
the inner membrane (IM). Monomer assembly is facilitated by diffusion and electrostatic 
interactions between the incoming Glu5 (monomer n) to the pre-existing Phe1 subunit (n+1). For 
the helix to be assembled, adenosine triphosphate (ATP) bound to the hexameric ATPase must be 
hydrolyzed from the cytosol, inducing a conformational change. The new conformation allows for 
piston-like movement in the membrane binding partner (MBP) protein. Once the fiber filament 
has extended 10.5 Å from the outer membrane (OM), ATP replaces bound ADP and MBP returns 
(A) (B) (C) 
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to its initial position. The addition of pili monomers within the IM occurs in three active sites 
surrounding the filament diameter. Figure 1.4 represents the addition at one active site.28 
 
 
Figure 1.4. The proposed mechanism of pilus assembly. (1) Addition of subunit n to the growing 
pilus filament. (2) Hydrolysis of ATP. (3) Hydrolyzed ATP induces piston-like motion of the 
membrane bound protein (MBP). (4) Pilus filament extended 10.5 Å into the periplasm. (5) 
Exchange to ATP, back to resting position. Adapted from Craig et al., 2006.28   
 
Recently, Chang et al.36 further explored type IVa pili assembly and disassembly with 
intact Myxococcus xanthus cells, using X-ray crystallography and cryo-electron tomography 
(Cryo-ET). This nano-machine spans both the inner and outer membrane and is comprised of 
following: the outer membrane pore, periplasmic stem, cytoplasmic disc and dome, three-
connected periplasmic rings, and a ring within the cytoplasm.37 A total of 10 proteins constitute 
the type IV pili machinery (T4PM): PilQ, PilP, TsaP, PilN, PilO, PilA, PilC, PilB, PilT, and PilM. 
The major pilin protein, PilA, is found in the periplasmic space as single monomers until the 
assembly into a protein fiber is facilitated by PilC. Peptidoglycan-binding protein (Tsap) forms the 
periplasmic ring around PilQ, while the mid-periplasmic ring is composed of PilP. The lower 
periplasmic ring is constructed of PilO and PilN, connected by coiled-coils that extend to the IM 
until it reaches the PilM in the cytosolic ring. Hydrolysis of the triple ATPase PilB induces rotation 
of PilC in order to drive the PilA fiber through the OM. Once PilA adheres to a surface, it relays a 
` 
 8 
signal back to the T4PM to induce a conformational change that releases PilB. PilT can then bind, 
which allows PilC to rotate in a manner that disassembles PilA monomers from the fiber.36   
 
Figure 1.5. Type IV pilus machinery. A representation between piliated and non-piliated T4P 
machinery containing 10 different proteins. PilB binds at the basal body of PilM with PilC and is 
involved in the extraction of PilA and PilT in the retraction of PilA. PilB is absent in the non-
piliated structure, therefore not involved in pilus retraction. PilQ extends from the outer membrane 
into the periplasm, the periplasmic ring encompassing PilQ is composed of Tsap and the mid-
periplasmic ring is composed of PilP. Adapted from Chang et al., 2016.36 
 
1.2.4. Pili Secreted by P. aeruginosa  
P. aeruginosa causes respiratory infections with patients whose immune systems are 
compromised when suffering from diseases such as cancer, cystic fibrosis, as well as patients 
recuperating in intensive care units.38 Infection by P. aeruginosa can become chronic, seen with 
biofilm formation in cystic fibrosis patients.39 Pili secreted on the surface of P. aeruginosa have 
been rigorously studied due to their ability to adhere to host cells.40 The different clinical strains 
of P. aeruginosa retain a consistent pilin structure, variability is observed within the C-terminal 
and D-regions. The D-region is able to bind to the cell surface receptor, asialo-GM1 and GM2, and 
is a potential target for cross-reactive vaccines. Development of cross-reactive vaccines for these 
targets requires the detailed study of structural differences, the effects of targeted binding on the 
Piliated Piliated Non-piliated Non-piliated 
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pili, and factors that contribute to immunogenicity.41 To generate a cross-reactive vaccine, the goal 
is to synthesize an antibody that will undergo a conformational change and fit into the binding 
regions of P. aeruginosa pili strains PAK, KB7, P1, and PAO. The antibody PAK-13 was selected 
for pili binding and was found to block adherence by interacting with the receptor binding site. 
The receptor binding domain, which was characterized by nuclear magnetic resonance (NMR) 
with the antibody, confirmed the presence of two 𝛽-turns. It was also found that the sequence 
elements required for binding was in the form of: Asp134-X-X-Phe137 and Pro139-X-Gly-Cys143 
(where X is any residue), demonstrating that cross-reactive antibody recognition is possible.41,42  
Site-directed mutagenesis of specific residues in the binding region mapped the binding 
affinity of KB7 and PAK to A549 cells.43 Important residues for this affinity were determined to 
be: Ser131, Gln136, Ile138, Pro139, Gly141, and Lys144. The disulfide bridge of cysteines 129 
and 142 was also important for receptor recognition. In KB7, the residues of importance were 
found to be: Ala130, Thr131, Thr132, Val133, Asp134, Ala135, Lys136, Arg138, and Pro139. 
Receptor binding motif (Adhesintope) mapping confirmed that the backbone conformations of 
PAK and KB7 are very similar within the two 𝛽-turn regions. While changing several residues 
does not affect receptor interactions, in PAK and KB7,40 the exact positions of basic or charged 
residues differs. The receptor binding site for Ile138 in PAK is replaced by Arg138 in KB7, with 
Val133 maintaining hydrophobicity, while the positive charge from the main residue Lys144 in 
PAK is replaced by Arg138 or Lys136 in KB7.  
 
1.2.5. In vitro Assembly of T4P-like Nanotubes  
Type IV pili form robust nanofibers, and interestingly, their truncated monomers have been 
used to synthesize protein nanotubes (PNTs) in vitro.44 It was observed that pilin monomers can 
be used to form PNTs using a size-exclusion (SEC) Superdex column, indicating that hydrophobic 
probes induce oligomerization. Previously, it was hypothesized that filament formation must occur 
with T4P machinery to drive assembly, and yet recent work has determined otherwise.44 Soluble 
protein nanotubes generated what resembled T4P filaments in vitro, and PNTs generated had a 
total length of 100 𝜇m, an outer diameter of 6 nm, and an inner diameter of 2 nm.44  The increased 
length is thought to be a consequence of a lack of T4P machinery, however the overall PNTs 
generated resembled the structure and function of T4P.22,23,45 Particularly, it was surprising to 
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observe PNTs with the truncated P. aeruginosa monomer DK122-4, since the N-terminal 𝛼-helical 
domain was hypothesized to play a major role in fiber formation.38 Oligomerization of DK122-4 
was induced by a hydrophobic probe44 (C11-SH), and was not incorporated into the nanofiber as a 
replacement for the N-terminal 𝛼-helix. This was observed with a constrained hydrophobe 
covalently attached to maleimide-activated plates.38  
 
1.3. Peptidyl-Prolyl cis,trans-Isomerase from Helicobacter pylori 
1.3.1. H. pylori 
The gram-negative H. pylori infects 50%46 of the global population, about 15-20%47 
progress to develop peptic ulcers,48 cell death,49 and adenocarcinomas.50 Severity of infection is 
dependent on the strain of H. pylori, as well as the innate immunity of the host. As with any 
pathogenic bacterium, H. pylori secretes several virulent proteins that include, but are not limited 
to: Vacoulating cytotoxin (VacA),51 urease,52 γ-glutamyl transpeptidase,53 Cytotoxin associated 
gene A (CagA),53 and HP0175.54 VacA increases the formation of vacuoles in the cytoplasm of 
gastric cells and disrupts mitochondrial function.51 CagA utilizes a type IV secretion system to 
translocate into the cytoplasm where it becomes phosphorylated, and activates interleukin-8 (IL-
8).53 Regulation of apoptosis by H. pylori has been linked to multiple proteins, however the 
peptidyl-prolyl cis, trans-isomerase HP0175 has been shown to increase the rate of apoptosis.50  
Patients infected with H. pylori elicit an up-regulated pro-inflammatory response mediated 
by macrophages, chemokines, and cytokines.55,56 HP0175 increases the activation of human 
effector T-cells (Th17), through its interaction with the Toll-like Receptor 4 (TLR4) pathway.57 
Key secreted cytokines associated with Th17 involved in activating other pro-inflammatory 
pathways include: IL-	𝛽1, IL-6, IL-17,58 IL-21, and transforming growth factor-𝛽 (TGF-𝛽).59 The 
HP0175 activated cytokine IL-𝛽1 can directly affect epithelial cells, and has been implicated in 
the progression of gastric cancer.60,61 TGF-𝛽 upregulates vascular endothelial growth factor 
(VEGF), which increases the production of blood vessels.62,63 IL-21 can stimulate the 
overproduction of matrix metalloproteinase (MMP)-2 and MMP-9, leading to matrix degradation 
to further contribute to tumour malignancy and invasion.64 Patients infected with H. pylori and 
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diagnosed with gastric cancer were found to have increased levels of  IL-23 and IL-17 within 
gastric tissue.65 
Inflammation of gastric tissue is a distinguishing feature of H. pylori infection.66 Most H. 
pylori infections progress into chronic gastritis, associated with an inadequate immune response 
against the bacterium.66 The adaptive immune response activates a signalling cascade facilitated 
by TLRs expressed on mucosal epithelium in order to identify pathogen-associated molecular 
patterns (PAMPs).67 Since H. pylori is a gram-negative bacterium, it is directly recognizable by 
TLR4 through its lipopolysaccharide (LPS).68 It was also observed that H. pylori increased the 
expression levels of TLR4 at the apical cell surface.67,69 Activation of the TLR4 complex triggers 
activation of the nuclear factor Kappa B (NF-𝜅B) pathway, which further activates pro-
inflammatory cytokines and the IL-8 pathway.66–68 
 
1.3.2. Peptidyl-Prolyl cis,trans-Isomerases 
Peptidyl prolyl cis, trans- isomerases (PPIases) are involved in the correct folding of newly 
synthesized proteins within the cell. Folding occurs with the isomerization of imidic peptide bonds 
N-terminal to protein residues, from cis to trans.70 The trans conformation of amino acid side 
chains are favoured over the cis conformation, since it is associated with steric hindrance and 
releases a free energy difference of 2.6 kcal/mol (Figure 1.6A). The free energy difference for a 
peptidyl proline side chain is 0.5 kcal/mol between cis and trans conformations (Figure 1.6B).71,72 
Characterization of PPIases further subdivides them based on drug specificity: 1) cyclosporine A 
(CsA)-binding cyclophilins,73 2) FK506-binding proteins (FKBPs), and 3) parvulin-like74 PPIases 
that do not bind to immunosuppressants (Figure 1.7).75 PPIases are classified as globular proteins 
which primarily consist of 𝛽-folds in the central region (Figure 1.7).76 FKBP proteins are 
characterized by the structure of FK506 (Figure 1.7A), which contains four anti-parallel 𝛽-strands 
and one 𝛼-helix. The overall structure of cyclophilin PpiB is a 𝛽-barrel, composed of eight anti-
parallel 𝛽-strands surrounding a hydrophobic core while two short 310 helices lie above and below 
the 𝛽-sheet (Figure 1.7B).77 The parvulin subfamily of PPIases represented by human peptidyl-
prolyl cis,trans-isomerase NIMA-interacting 1, encoded by gene Pin1 (Figure 1.7C), is composed 
of two anti-parallel 𝛽-strands surrounded by four 𝛼-helices. Although PPIases are known for 
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catalyzing peptide bonds preceding proline residues, studies have demonstrated that protein-
protein interactions still occur even with PPIase domain removal.76,78 This has now expanded the 
role of PPIases to include an association with signal transduction, as well as gene regulation on 
both transcriptional and translational levels.78  
 
Figure 1.6. Cis- and trans- isomers of the peptide bond. (A) Denotes a general structure of a 
protein amide backbone. In the trans-configuration, the side chains R1 and R2 are not within close 
proximity. In the cis-configuration, side chains R1 and R2 could clash. (B) The peptide bond of 
proline. The trans- and cis-configurations both demonstrate rigidity, however the cis-conformation 




Figure 1.7. Ribbon representation of three peptidyl prolyl isomerase families. (A) The FKB12 
protein regulates cell growth and metabolism in humans. Its classification is based on its ability to 
bind to the immunosuppressant FK506. Crystallographic representation of its PPIase: a four-
stranded anti-parallel 𝛽-sheet below two 𝛼-helices (PDB ID: 1FKJ).79 (B) E. coli cyclophilin PpiB, 
found in the cytoplasm binds to the immunosuppressant CsA. Overall structure of this PPIase 
domain is a 𝛽-barrel, with eight anti-parallel 𝛽-strands located between two 𝛼-helices (PDB ID: 
2NUL).77 (C) Parvulin type PPIase; represented by human Pin1 involved in the regulation of G2/M 
transition of eukaryotic cells. The PPIase domain (residues 43-163) are depicted with two anti-
parallel β-sheets and four	𝛼-helices (PDB ID: 1PIN). Partially adapted from Ünal and Steinert, 
2014.72 
(A) (B) (C) 
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1.3.3. HP0175 Induced Cell Death 
Cellular recognition of invaders such as pathogenic bacteria are usually performed by 
pathogen recognition receptors (PRRs). These PRRs recognize specific invariant structures 
through different sub categories of sensors; pathogen associated molecular patterns (PAMPs), 
TLRs, nucleotide binding oligomerization domain (NOD)-Like Receptors (NLR), and C-lectin 
receptors (CLR).80,81 HP0175 has been shown to interact with TLR4 and induce apoptosis.54 Pre-
incubation of HP0175 in human Caucasian Gastric Adenocarcinoma (AGS) cells with addition of 
anti-TLR4 resulted in the inhibition of apoptosis. The signaling pathway for cell death by HP0175 
functions through initial interaction with TLR4. TLR4 activates Apoptosis Signal regulating 
Kinase 1 (ASK1), which proceeds to activate p38 MAPK and caspase 8. Bid is cleaved and 
translocated to the mitochondria, cytochrome c is released from the mitochondria due to the 
membrane potential loss which subsequently releases caspase 9 and 3, and cell death occurs 
(Figure 1.8).54 Additionally, cell lysates containing TLR4 can be pulled down by immobilized 
HP0175 on Ni2+-NTA agarose, confirming an interaction between TLR4.82 Inhibited p38 MAPK 
decreased apoptosis induced cell death by HP0175, while ERK1/2 MAPK had no effect. Since it 
was determined that p38 MAPK was involved in the apoptosis pathway, as a default from the 
known cascade, so is ASK1, a member of the kinase kinase family is also involved.83–85 
 
1.3.4. Overview of Caspases 
Apoptosis is often referred to as programmed cell death which is an important mechanism 
for central nervous system development, maintaining homeostasis and early brain development.86 
Caspases play an important role in cell death activation linked to their cysteine aspartate-specific 
protease, their primary function is to cleave peptide bonds of aspartic acid residues.87 Caspases are 
present as inactive pre-cursors (procaspases) in the cell until activated by specific cell death 
signals. Two distinct pathways highlighted are the initiation of death receptors tumor necrosis 
factor (TNF) or Fas, requiring Caspase 8 or 10 in the receptor complex. Activated caspase 8 is able 
to further cleave downstream caspases such as caspase 7 or 3 that lead to apoptosis.88 While an 
interesting pathway includes the activation through a stimuli that causes hypoxic stress, 
chemotherapeutic agents, growth factor withdrawal or irradiation that induces mitochondrial 
damage allowing for the release of cytochrome c. Cytochrome c complexed with dATP interacts 
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with Apaf-1, induces a conformational change and activates Caspase 9, which further cleaves 
downstream caspases.89  
 
 
Figure 1.8. Schematic representation of the multiple pathways associated with cell death and 
autophagy. Apoptosis pathways outlined represent mediation by extrinsic pathway involving cell 
surface receptors, intrinsic pathway utilizing mitochondria and endoplasmic reticulum. Additional 
pathway delivers porforin by cytolytic T and NK cells. The pathways of interest for the H. pylori 
induced cell death focuses on nuclear factor Kappa B (NF-kB), caspase-8, -9, and -3, Bid, 





1.3.5. Toll-Like Receptors 
Toll-like receptors (TLRs) are membrane bound proteins involved in triggering immune 
responses due to their ability to recognize different pathogenic compounds, and are classified as 
pathogen recognition receptors (PRRs).91 There are ten TLR paralogs found in humans that 
respond to different PAMPs including: lipopeptides (TLR2 associated with TLR1 or TLR6), viral 
dsRNA (TLR3), viral or bacterial ssRNA (TLRs 7 and 8), lipopolysaccharide (TLR4), bacterial 
flagellin (TLR5), CpG-rich unmethylated DNA (TLR9), and several others. TLR paralogs are 
located within the membrane of endosomes; their function is to defend against pathogenic 
organisms and compounds. TLRs are type I integral membrane receptors and are composed of N-
terminal ligand recognition domain, single transmembrane helix and a C-terminal cytoplasmic 
signaling domain. The TLR signaling domain is referred to as Toll IL-1 receptor due to its 
homology to the IL-1R family. In most TLRs these signaling domains are the ones that interact 
with the pathogens and can initiate the signaling cascade.92 A cascade of signalling occurs when a 
ligand or molecule bind to the extracellular domain of TLR and induces a conformational change 
within the intracellular domain.93  
When TLRs bind to their specific target ligand, they transmit signals through myeloid 
differentiation primary response protein 88 (MyD88) followed by TIR domain and tumor necrosis 
receptor associated with factor 6 (TRAF6).94 MyD88 also transmits signals that result in 
inflammatory chemokines. Association of TLRs and MyD88 activates interleukin 1 receptor 
associated kinase (IRAK) family. Phosphorylation of IRAK1 and IRAK4 is observed and 
dissociated from MyD88 results in activation of (TRAF6), that subsequently goes on to activate 
transforming growth factor B-activated protein kinase 1 (TAK1). Another pathway of signaling 
from TLRs and MyD88 is the phosphorylation of inhibitor Kappa B kinase (IKK) enzyme 
complex, and mitogen activated protein (MAP) kinase.95 Eventually, activated NF-𝜅B translocates 
to the nucleus for the transcription of pro-inflammatory genes such as inflammatory cytokines, 





TLR4 is well known for activating an immune response through its ability to recognize 
lipopolysaccharides found on the surface of gram-negative bacteria.96 The recognition of 
pathogens involves hetero-dimerization with myeloid differentiation factor 2 (MD-2) as 
represented by the crystallographic structure in Figure 1.9.96 Previous data by Park et al. (2009)96 
demonstrated that TLR4 behaves in complex with MD-2, where binding of the pathogen is 
recognized by the hydrophobic pocket of MD-2. With the lipopolysaccharide tested, five of the six 
chains of LPS interact with MD-2 buried in the hydrophobic pocket, induces a slight 
conformational change that allows for TLR4 and MD-2 to interact through hydrophilic residues. 
Once LPS binds to MD-2, it bridges the two MD-2’s and forms a multimeric complex in the shape 
of an M.96  
                 
Figure 1.9. Crystal structure of TLR4-MD-2 complex bound to LPS. TLR4 and MD-2 interact 
to form a heterodimer that can recognize a certain pattern of lipopolysaccharides secreted by gram-
negative bacteria. TLR4 is represented in blue and green (dimer), MD-2 is represented in grey and 
the lipopolysaccharide is divided in red (LPS) and pink (Lipid A). Adapted from Park et al., 2009 





1.3.6. Crystal Structure of I2CA bound HP0175 
The crystal structure of HP0175 or referred to as H. pylori cell-binding factor 2 (HpCBF2) 
has been recently reported by Naveen et al. (2016).97 The protein was crystallized bound to indole 
2-carboxylic acid (I2CA), a recognised inhibitor of parvulin-type PPIases. Data was acquired to 
2.4 Å using the National Synchrotron Radiation Research Center of Taiwan (Hsinchu, Taiwan), 
and Se-Methionine derivative crystals were used to obtain initial phases. It was crystallized in the 
space group P3121 with unit cell parameters a=b= 62.0 Å and c=366.4 Å, and Mathews coefficient 
of 3.16 Å3, corresponding to 61% solvent content comprising a homodimer in the asymmetric 
unit.97 Analytical ultracentrifugation identified the molecular weight of HP0175 to be 60.4 kDa, 
suggesting a dimer in solution. The structure represented 2 𝛼-helices in the N-(54-153) and 1 𝛼-
helix in the C-(261-296) terminal, with two short antiparallel 𝛽-strands (Figure 1.10). The PPIase 
domain is composed of 4-antiparallel 𝛽-sheets surrounded by four 𝛼-helices. Binding of the 
inhibitor ligand is found near 𝛼6 and 𝛽4 -	𝛼7 and 𝛽5 - 𝛽6.97 Previously, no structural data on the 
native un-liganded HP0175 was available. Therefore, comparative analysis of I2CA-HP0175 was 
performed with other proteins within the parvulin PPIase family, in particular comparison against 
Campylobacter jejuni PEB4 (CjPEB4),98 Bacillus subtilis PrsA (BsPrsA)99 and E. coli SurA 
(EcSurA).100  
Construction of the apo and I2CA-bound HP0175 structures utilizing ab initio calculation 
through their small angle X-ray scattering (SAXS) profiles resulted in different overall shapes. 
Examination of the generated shapes from the top view, I2CA-HP0175 resembles a V and apo-
HP0175 resembles that of a W-shape (Figure 1.11). This indicates a slight difference in 
conformation between the apo- and I2CA-bound proteins. The crystal structure of HP0175 has a 
strong resemblance to other PPIases within the Parvulin type family. The comparison obtained a 
root mean square deviation of 0.4 Å for 75 of 98 C𝛼 atoms to CjPEB4, 0.6 Å for 61 of 89 C𝛼 
atoms in BsPrsA and 1.8 Å for 77 of 105 C𝛼 atoms in EcSurA. The CjPEB4 also contained a 
domain-swapped manner that interlocked the two homodimers together, similar to the one 




Figure 1.10. Crystal structure of HP0175 complexed with I2CA. (A) Dimeric representation of 
I2CA-HP0175, crystallized in space group P3121, resolution range 30-2.4 Å with unit cell 
parameters of a=b=62.0, c=366.4 Å. (B) Monomeric representation of I2CA-HP0175. The binding 
pocket of I2CA domain is involved with residues K165, H161, D199, L211, M219, F223, F244 
and H247. Labelling of helices and β sheets is depicted in (PDB entry 5EZ1) (B). Adapted from 








Figure 1.11. SAXS analysis of apo-HP0175 and I2CA-bound HP0175. Ab initio reconstruction 
of native HP0175 (blue) and I2CA-bound HP0175 (pink) based on merging 20 independent 
models. Representing a smaller crevice for the I2CA-bound HP0175 in comparison to the native. 
Top view of native HP0175 demonstrates a W, while the I2CA-bound reveals a V shape. Adapted 











1.4. A Brief Primer on Structural Biology by X-ray Crystallography  
1.4.1. Initial Crystallization Trials 
Protein crystals are composed of an ordered and repeating array of protein in a 
thermodynamically stable environment. Crystallization of macromolecules has often been referred 
to as a ‘black box’, with the majority of the experiment left for trial and error. While crystallization 
of macromolecules has been predominantly an empirical process, methods have been introduced 
to favor crystal growth. Controllable factors such as protein concentration, purity, pH, salts and 
cryoprotectants have been utilized as parameters that can be altered for crystal growth. Increasing 
protein concentration will increase the likelihood of protein-protein interaction and decrease 
protein-solution interaction, favouring crystallization. Adjustment of the pH of a solution has an 
impact on protein solubility, the closer the pH of a solution is to the isoelectric point of a protein 
solubility is decreased, less solvation and favouring crystallization. The addition of salts or 
cryoprotectants decreases protein-solution interaction by increasing salt-solution interactions, 
thereby increasing protein-protein interactions. The effect of multiple variables influencing 
crystallization can be represented in a 2D schematic diagram (Figure 1.12), the phase of the protein 
is characterized with respect to environmental influences. The phase diagram is composed of 
multiple regions; undersaturation, saturation, metastable and precipitation. Undersaturation 
represents a single liquid phase, saturation denotes a crystal will remain in equilibrium within the 
solution. Metastable, or a supersaturated solution would continue growth on the surface of a 










Figure 1.12. Protein solubility curve. Adjustable parameters are plotted with protein 
concentration and salts, PEG (cryoprotectant) and temperature. Undersaturated; low concentration 
of protein, would not crystallize. Metastable; within the supersaturation region, where the protein 
crystal is in equilibrium with the environment/solution it is in. Nucleation; growth of crystal nuclei 
where protein crystals can grow and move to the metastable region. Precipitation occurs with a 






Figure 1.13. Representation of vapour diffusion for crystallization. Initial screening was 
performed with sitting drop vapour diffusion (A) sealed with tape. While optimization was 
performed with hanging drop (B) sealed with vacuum grease.103  
 
1.4.2. Optimization with Microseeding 
Many crystals obtained through initial screening do not diffract to high resolution and 
therefore require further refinement. A common method to enhance crystal quality is through 
utilizing poorly diffracted crystals for nucleation, a process known as seeding, and has become a 
powerful tool for generating higher resolution crystals for diffraction. Seeding can be done using 
(A) Sitting drop (B) Hanging drop 
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larger crystals, a process known as macroseeding, or by crushing seed crystals to make 
microcrystals for seeding, and accordingly known as microseeding. Seeding involves the transfer 
of crystalline material as a nucleation site in a new crystallization experiment with similar 
conditions.104 To further elaborate, de-novo nucleation is bypassed by the addition of a crystal that 
acts as a nucleation site where crystal growth can proceed. Macroseeding focuses on the transfer 
of one crystal into a newly equilibrated drop, the chosen crystal is rinsed to remove any unwanted 
nucleation sites prior to transferring. In microseeding, a crystal is crushed into many smaller 
crystals and transferred to a newly equilibrated protein and buffer drop.104 In addition, 
microseeding can be administered into a new drop by serial dilution and pipetting or by using cat 
whiskers or horse hair for streaking. Whiskers and hair contain rough edges allowing crystals to 
adhere, thereby enabling transfer to the new drop. Crystals can also be added to an optimization 
screen known as microseed matrix screening (MMS; Figure 1.14),105 or they can be added in re-
screening new conditions, a process known as random matrix microseed screening (RMMS).106 
 
Figure 1.14. Adjustment of seed stock concentration on crystallization. Sitting drop vapour 
diffusion was used to represent the effect of seed stock concentration on the growth of tyrosine 
kinase. The seed stock was composed of crystals that were grown in 10 mM HEPES (pH 7.0), 8% 
(w/v) PEG800, and 7% (v/v) ethylene glycol. MMS crystallization was performed and identified 
a condition with 0.1 M MES pH 6.5, 25% (w/v) PEG 550 monomethyl ether (MME). In the above, 
drops represent seeding with (A) undiluted microseed stock, (B) a 1:100 dilution and (C) 1:1000 
dilution of the microseed stock, which provided the best results. Adapted from D’Arcy et al. 105 
 
1.4.3. Diffraction, Structure Solution and Refinement 
Structural characterization of proteins in three-dimensions is an important aspect to 
understanding their function and in the development of therapeutic drugs.107,108 There are several 
(A) (B) (C) 
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methods that can characterize the structure of biological systems such as Cryo-electron microscopy 
(Cryo-EM), transmission electron microscopy (TEM), nuclear magnetic resonance (NMR), X-ray 
crystallography, and mass spectrometry. Each of these methods contain their own distinct 
advantages and limitations, nonetheless, when utilized together can provide powerful insight and 
validation on the systems studied. In respect to atomic resolution, X-ray crystallography currently 
remains the only method that can characterize a range of molecules, from large proteins to small 
organic and inorganic molecules to an angstrom metric.109  
Viewing the structure of proteins requires a brief understanding of wavelengths and optics 
in re-generating an image. Objects are not viewed in terms of wavelengths but rather as images 
attributed to the lenses in our retinas focusing the light diffracted by objects. The wavelength of 
visible light (electromagnetic radiation) is between 400-700 nm, these wavelengths are also used 
by cameras, microscopes and retinas. In order to view smaller sizes such as those for molecules 
and proteins, we require a wavelength small enough to match bonding of atoms calculated around 
0.15 nm or 1.5 Å. Positions of hydrogen atoms for protein molecules are often generated from 
bond angles and conformation assumptions based on small molecules.109 Determination of a 
crystal structure is not as straightforward as the extraction of an image from a lens, where the 
construction of wavelength interference are collected as intensities.    
Monochromatic X-rays are diffracted by electrons within the crystal, the magnitude of the 
diffracted beam is dependent on the number of electrons in each atom. The diffraction pattern 
generated by a crystal is described as an array of intensities observed in a regular net or reciprocal 
lattice. Sir W.H. Bragg and Sir W.L. Bragg explained this phenomenon in what is known as the 
Bragg Law (Equation 1): 
Equation 1:   𝟐	𝒅 𝐬𝐢𝐧 𝜽 = 	𝒏𝝀 
where d represents the spacing between atomic layers within the crystal planes, lambda (𝜆) 
represents wavelength of the incident beam, theta (𝜃) is the angle of reflection, and n is an 
integer.109  
The reflections observed in a diffraction pattern represent a summation of waves that travel 
from the electron positions in the lattice. Since waves can add constructively and destructively, 
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amplitude can be calculated from the intensity of the reflection, but the phase (∅) is lost; this is 
largely referred to as the crystallographic phase problem. The following is required for the 
generation of the electron density map exemplified by the Fourier transform (Equation 2). Over 
the years several methods have been developed for solving the phase problem and generating 
electron density, such as direct methods, single wavelength anomalous dispersion (SAD) and 
molecular replacement. 
Equation 2:             𝝆	(𝒙𝒚𝒛) = :𝟏𝑽= |∑ 𝑭(𝒉𝒌𝒍)|{𝐞𝐱𝐩(𝒊∅) 𝐞𝐱𝐩(−𝟐	𝝅	𝒊	(𝒉𝒙 + 𝒌𝒚+ 𝒍𝒛)}		𝒉𝒌𝒍  
 
Molecular replacement utilizes the coordinates of a previously determined structure to 
generate the phases for the unknown protein crystal, assuming amino acids applied in a similar 
sequence will contain similar folds. Relating the known protein’s phase for the unknown crystal 
requires search for rotation and translation. Rotation function (RF) is defined as the spatial 
orientation of the known and unknown structure with respect to each other for determining the 
spatial orientation of the unknown crystal. The second is translational function (TF) for 
determining the exact position in the unit cell for the superposition of structure in the new unit cell 
with the correct orientation. Packing analysis is performed following RF and TF to determine any 
clashes between atoms of symmetry related molecules. In the last stage, rigid body refinement is 
performed on the final model and the phase is calculated. A problem that arises from this method 
is structural bias imposed from the previously determined protein structure.110 Selection of the 
model used for molecular replacement must be similar in structure or sequence to the unknown 
crystal, with an RMSD variation less than 1.5 Å, or based on sequence identity greater than 20-
30%.110 
 
1.5. Thesis Research Objective and Overview 
Bacterial infections are common in our society and continue to evolve. There is much we 
do not know from their behaviour, function and adaptation strategies. Further investigation on 
different strains and various machineries encompassing their behaviour would pose a beneficial 
strategy to generate a novel mode of disruption. Infections obtained from strains such as 
Electron density Amplitude (Structure factor) 
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Pseudomonas aeruginosa are commonly found in individuals with a comprised immune system 
such as burn victims, cystic fibrosis, acute leukaemia and HIV patients.111,112 An important 
characteristic of this bacteria is through the adhesion by pili which utilize complex machinery as 
seen with T4P that bind to biotic and abiotic surfaces.38 In addition, the bacterium H. pylori, 
associated with peptic ulcers48 and adenocarcinomas,50 is associated with multiple proteins that 
contribute to the following through activation of the adaptive immune system. HP0175 is involved 
with activating cell death, causing inflammation at a more significant rate, making the study of the 
protein important.  
The overall objective of the research outlined within this thesis is to examine proteins 
secreted by pathogenic bacteria through X-ray crystallography, specifically the KB7 and P1 pilins 
secreted by Pseudomonas aeruginosa and HP0175 of Helicobacter pylori. Characterization of a 
protein’s structure will provide information on how it behaves and how it may differ from other 
proteins within the family. As in P. aeruginosa, the overall structure of the pilin secreted remains 
similar with variability of the D-region. Crystallographic determination of the pilins would 
highlight how bacteria evades eradication through sequence alterations, which could lead to the 
synthesis of cross-reactive vaccines. Examination of the structure of apo-HP0175 from H. pylori 
will provide insight into how the protein functions and its conformational changes upon substrate 
binding. Previously, parvulin peptidyl prolyl isomerases were only observed structurally in one 
configuration; either in a bounded or un-bounded state. Here we show the changes of HP0175 
undergone upon targeted interaction with indole-2-carboxylic acid and infer on the changes when 










Chapter 2: Experimental Methods 
2.1. Materials and Methods 
Chemicals and antibiotics used in the following study were purchased from Sigma-Aldrich, 
Alfa Aesar, VWR, Hampton Research, Fischer Scientific, Bio Basic, J.T. Baker, Anachemia, 
Amresco and EMD. Restriction enzymes, DNA ladders and DNA staining were purchased from 
New England Biolabs (NEB). Plasmid vectors pGEX-4T2, pET28a:HP0175 and E. coli BL21 
(DE3) and DH5𝛼 were obtained from cryogenic lab stocks. Final concentrations of antibiotics 
utilized were 50 µg/mL Kanamycin (Km) and 100 µg/mL Ampicillin (Amp). A list of all primers 
for the cloning of pilin proteins are represented in Table 2.1.  
Liquid chromatography was performed on an ÄKTA Purifier 10 (GE Healthcare); all 
columns were purchased from GE Healthcare, Phenomenex and Wyatt. Resins for the purification 
of proteins were purchased from Fisher scientific. Polymerase chain reactions were performed 
using a TECHNE PCR thermocycler. Displacement of proteins from the cytoplasm was performed 
via sonication on a Sonic Dismembrator 500 (Fisher Scientific). Electrospray ionization mass 
spectrometry was performed on a Waters Synapt G1 instrument. Concentrating proteins to the 
appropriate volumes were completed using 10,000 and 30,000 Da molecular weight cut off 
(MWCO) centrifugal concentrators (Fisher Scientific, GE Healthcare). Observation of 
crystallization experiments were conducted using a Nikon SMZ1500-Fibre Lite MI 150 
stereoscopic microscope. Diffraction studies were carried utilizing Rigaku 007HF MicroMax 
Rotating Anode with Saturn 944+ CCD detector.  Data of protein crystals were collected with 
beamline 08ID-1 and 08B1-1 of the Canadian Macromolecular Crystallography Facility (CMCF) 
at the Canadian Light Source (CLS) in Saskatoon, Saskatchewan. 






KB7_Forward EcoRI 57.5 ATGAGAATTCTATCTCGCTCTCAGGTC 
KB7_Reverse XhoI 59.6 CTTACTCGAGTTATCAGTCCGACGTTGTAAAC 
P1_Forward EcoRI 63.2 TATTCGAATTCTCGCCCGTACCCAGGT G 
P1_Reverse XhoI 65.5 TTGATTCTCGAGTCATCA 
CATTAGCCGGAGCGTAGT TGG 
*Underlined are the restriction enzyme cut sites EcoRI and XhoI. Δ refers to the truncated KB7and P1 pilin which 
consists the removal of amino acids 1-28. 
` 
 26 
2.2. Generation of Competent DH5𝜶 and BL21 (DE3) Cells 
Overnight cultures of DH5𝛼 cells were prepared in 20 mL LB.  From the overnight culture, 
1 mL was transferred to a total of 100 mL fresh LB and inoculated at 37 °C/200 rpm until mid-log 
phase growth (OD600= 0.4-0.7). Pipette tips, falcon tubes, microfuge tubes, ddH2O and 100 mM 
CaCl2 were pre-chilled at 4 °C. The cells were placed on ice for 10 minutes followed by 
centrifugation (2 x 50 mL), 10 minutes at 2,700 x g and 4 °C. Cell cultures were re-suspended with 
1.6 mL ice cold 100 mM CaCl2 and incubated on ice for 30 minutes. Cells were centrifuged, re-
suspended in 100 mM CaCl2 and incubated on ice for 20 minutes. Ice-cold glycerol (0.5 mL, 80%) 
was added to 3.2 mL of DH5𝛼 cells. Competent cells were stored for a period of 6 months in -80 
°C. The same procedure was followed for the generation of competent BL21 (DE3) cells.  
 
2.3. Cloning P. aeruginosa pili ΔKB7 and ΔP1 
2.3.1.  Plasmid Extraction of ΔKB7 and ΔP1 from pMAL p2 [tm] 
Overnight cultures of pMAL:ΔKB7, pMAL:ΔP1 and empty pGEX-4T2 in DH5𝛼 were 
prepared with 20 mL LB and 20 µL Ampicillin (100 µg/mL) from laboratory stocks. Plasmid 
extraction was performed with GeneJet plasmid mini-prep kit following manufacturers protocol 
from 6-8 mL of overnight cultures. Concentrations of each plasmid were determined using a 
NanoDrop 2000 Spectrophotometer, and verified on a 1.2% agarose gel (1.2 g agarose with 1X 
TAE buffer: 40 mM Tris:HCl pH 8.5, 20 mM acetic acid and 1 mM EDTA were incubated at 65 
°C to dissolve and added with 0.2 mg/mL ethidium bromide).  
 
2.3.2. PCR Amplification of ΔKB7 and ΔP1 
Primers utilized in this study followed design guidelines presented by European Molecular 
Biology Laboratory (EMBL).113 The following guidelines included appropriate GC content (40-
60%), melting temperature for the forward and reverse primer being within 3-5°C (Table 2.2), the 
temperature to generate hairpins being lower than the annealing temperature, and the free energy 
of homo- and hetero- dimerization were below -10 kJ and 30 °C.114 PCR amplification parameters 
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were: initial denaturation for 5 minutes at 98 °C, annealing temperatures were 5 °C below the Tm 
of the primers, 72 °C extension step, with a final extension at 72 °C for 7 minutes, and held at 4 
°C. PCR amplicons of ΔKB7 and ΔP1 were PCR purified for restriction enzyme digestion.  
 
2.3.3. Restriction Enzyme Double-Digestion  
Restriction enzyme digestion on the PCR amplicon of ΔP1 and ΔKB7 were performed 
following parameters of NEB kit outlined in Table 2.2. The target plasmid pGEX-4T2 was also 
double digested to create complementary sticky ends with XhoI and EcoRI restriction enzyme 
sites.  Plasmid vectors and PCR amplicons were gel extracted following double digestion to ensure 
removal of the enzymes.  
Table 2.2. Restriction enzyme double digestion 
Components Volume (µL) Final Concentration 
ddH2O To 50   
PCR amplicon  1 µg 
10X NEB Buffer 2.1 5 1 X 
XhoI 0.5 20, 000 units 
EcoRI-HF 0.5 20, 000 units 
Double digestion was carried at 37 °C for 1-2-hour incubation. 
 
2.3.4. Dephosphorylation of pGEX-4T2 
Calf Intestinal phosphatase (CIP) was used for de-phosphorylation of the 5’ and 3’ ends of 
the pGEX-4T2 plasmid. This ensured that plasmid used would not self-ligate, and therefore 
increase ligation efficiency with the PCR amplicons. CIP was incubated with pGEX-4T2 at 37 °C 
for 2 hours (2000 ng plasmid, 4 µL smart buffer and 1µL CIP).  
 
2.3.5. Ligation and Heat-Shock Transformation into DH5𝜶 Cells 
The mass of amplicon to plasmid were performed utilizing 1:3, 1:5 and 1:7 as well as self-
ligation trials. Calculations of masses (PCR amplicon to plasmid) were designed using NEB’s 
ligation calculator. The following was prepared with 2 µL ligase buffer, vector DNA, insert DNA, 
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ddH2O and 1 µL DNA ligase for a reaction total of 20 µL. Ligations were incubated at room 
temperature for 30 minutes followed by heat inactivation at 65 °C for 10 minutes. The samples 
were chilled on ice for 5 minutes prior to transforming 5 µL of the reaction to 20 µL DH5𝛼 
competent cells.  The transformed cells were incubated on ice for 20 minutes before incubation at 
42 °C for 90 seconds, placed on ice again for 5 minutes and transferred into 300 µL LB for 1 hour 
at 37 °C and inoculated on agar plates containing Amp (100 µg/ml).  
 
2.3.6. Gene Extraction and Sequencing 
 In order to verify the correct placement of the gene, several colonies were inoculated 
overnight at 37 °C followed by gene extraction the following day. Restriction enzyme double 
digest with XhoI and EcoRI-HF were performed as per section 2.3.3. The plasmids containing the 
correct insert size as per 1.2% agarose gel after double digestion were sent for sequencing at The 
Centre for Applied Genomics (TCAG) at the Hospital for Sick Children (Toronto, ON). 
 
2.3.7. Heat-Shock Transformation into BL21 (DE3) Cells 
Plasmids containing the correct genes after sequencing were transformed into BL21 (DE3) 
competent cells as per section 2.3.5.  
 
2.4. Expression and Purification of GST-ΔKB7 and HP0175 
2.4.1. Expression Trials for GST-ΔKB7  
E. coli BL21 (DE3) cells containing pGEX-4T2:ΔKB7 were inoculated overnight at 37 °C 
in 20 mL LB, 1 mM dextrose and 50 µL Amp (100 µg/µL). Cell cultures were transferred to fresh 
50 mL LB and Terrific Broth (TB). The cells were expressed to mid log-phase (OD600 0.4-0.7) at 
37 °C/200 rpm. Only half of the cultures were induced while half were left to grow without 
induction, with a total expression of 4 hours. Cell pellets were harvested by centrifugation: 6000 
x g, 20 min, 4 °C, and stored at -20 °C. 
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2.4.2. Large Scale Expression 
E. coli BL21 (DE3) cells harbouring pGEX:ΔKB7 were grown overnight in LB at 37 °C. 
Aliquots of these cells were allowed to reach mid-log phase (OD600= 0.4-0.7) in 500 mL fresh LB 
containing Amp 100 µg/µL Amp and 1 mM dextrose. Protein expression was induced with the 
addition of isopropyl 𝛽-D-1-thiogalactopyranoside (IPTG) to a final concentration of 1 mM final 
for a total of 4 hours at 32 °C and 200 rpm. 
Glycerol stocks of HP0175 were originally a gift from our collaborator, Professor M. 
Kundu of the Bose Institute in Calcutta, India. HP0175 was N-terminally hexa-histidine tagged 
and expressed in E. coli BL21 (DE3) cells harboring the pET28a expression vector. From the 
overnight expression, cell cultures were grown to mid-log phase in terrific broth media (TB: 12g 
Tryptone, 24 g yeast extract, 4 mL 100% glycerol in 900 mL ddH2O, 100 mL salt containing 0.17 
M KH2PO4 and 0.72 M K2HPO4). Protein expression was also achieved by adding 1 mM IPTG 
and incubated for 4 hours in 32 °C/200 rpm. Cell pellets were harvested by centrifugation 6,000 x 
g, 30 min, 4 °C and stored for up to 6 months in -20 °C.  
 
2.5. Purification of GST- ΔKB7 and HP0175 
2.5.1. GST Affinity Purification of ΔKB7 
Cell pellets containing GST-ΔKB7 were re-suspended in lysis buffer (50 mM Tris pH 8.0, 
150 mM NaCl, 1 mM EDTA), incubated with lysozyme (1 mg/ml final concentration) for 1 hour 
with shaking at 4 °C. The sample was incubated with lysozyme to increase cell lysis efficiency by 
hydrolyzing the peptidoglycan layer, and therefore allowing ease of disruption through sonication. 
Release of GST-ΔKB7 was performed via sonication on ice for a total of 5 minutes with pulses 
(40 % amplitude, 15 s pulse on, 30 s pulse off). Cells were centrifuged at 45,000 x g, 30 mins at 4 
°C. Cell debris was removed by syringe filtration (0.8 µm) prior to loading onto a glutathione 
column. The use of GST as a tag is beneficial for solubilizing proteins that would otherwise 
become inclusion bodies. It is also easily removed from the sample through enzymatic digestion 
and re-purification on a glutathione column, size exclusion or ion exchange chromatography.115 
The elution buffer was composed of 20 mM Tris pH 8.0, 10 mM reduced glutathione and 150 mM 
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NaCl. Fractions containing GST-ΔKB7 were pooled, concentrated (30,000 MWCO; Millipore) 
and buffer exchanged for 36 hours via dialysis into 10 mM Tris:HCl pH 7.4. 
 
2.5.2. Immobilized Metal Affinity Purification of HP0175 
Cell pellets of pET28a:HP0175 were re-suspended in 1:10 (w/v) loading buffer (20 mM 
HEPES, 500 mM NaCl pH 7.4). Protein was released via sonication over a total of 5 minutes at 
30% amplitude with brief pulses (15 s on, 30 s off), following which samples were centrifuged at 
45,000 x g, 20 minutes at 4 °C. The supernatant was syringe filtered (0.8 µm) for removal of cell 
debris and purified with immobilized metal affinity chromatography (IMAC). Similar to the 
affinity purification used for GST-ΔKB7, the polyhistidine peptide is used as a tag and can bind 
to transition metals such as Ni2+, Co2+, Cu2+ and Zn2+. Immobilized Nickel (II) to nitrotriacetic 
acid (NTA) resin was used for the purification of HP0175.116 Fractions containing HP0175 (36 
kDa) were pooled and buffer exchanged overnight via dialysis into 10 mM HEPES pH 7.4 before 
concentrating with 10 K MWCO concentrators. Concentration and purity were verified with UV-
VIS and 12.5% sodium dodecyl sulfate protein agarose gel electrophoresis (SDS-PAGE). 
 
2.6. Crystallization of Macromolecules   
Initial crystallization trials for GST-ΔKB7 were prepared with sitting drop (Figure 1.13A) 
vapour diffusion (96-well Art Robins Instruments plates), buffers used for screening included 
MCSGII, MCSGIV, TOP96 and PurePEGs, purchased from Anatrace. Sitting drops were prepared 
with 1:1 protein-to-buffer ratio (0.6 µL) with a reservoir of 90 µL. The same plates were also 
arranged utilizing a reservoir comprising only 1.5 M NaCl to increase the rate of evaporation 
through high salt concentration and sealed with tape. Hanging drop vapour diffusion (Figure 
1.13B) was prepared for optimization of certain conditions, plastic slides containing protein and 
buffer drop (0.8 µL; 1:1 ratio) were sealed with grease above 1 mL reservoir in a 24-well plate. 
GST-ΔKB7 was screened within the range of 5-15 mg/ml.  
Initial crystallization trials for HP0175 were performed in sitting drop vapour diffusion 96-
well plates (ARI) with Microlytic MCSG II crystallization screen (Anatrace). The protein to buffer 
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ratio was 1:1 with protein density ranging from 5-20 mg/ml, 0.75 𝜇L protein: 0.75 𝜇L buffer. The 
following screen condition yielded a protein crystal in 0.1 M Tris:HCl pH 8.5 and 2.5 M 
ammonium sulfate; these conditions were optimized to generate spherulites in a 24-well plate 
hanging drop vapour diffusion (0.8 𝜇L protein: 0.8 𝜇L buffer content). The spherulites were 
crushed and used as a microseed stock following Hampton Microlytic seed bead kit; dilutions of 
the crushed crystal were made into 10-1, 10-2, 10-3 and 10-4. The seed stock was then added to the 
hanging drop optimization screen, after 48 hours to allow for equilibration. This optimization 
screen yielded a 7.8 Å diffracting crystal from reservoirs containing 0.1 M Tris:HCl pH 8.3 and 
47.4% ammonium acetate. The same concentrations of protein and microseed stock that provided 
the diffracting crystal were re-screened with fresh MCSG I-III buffers (Anatrace). The re-screened 
HP0175 (16.5 mg/ml) yielded a crystal that diffracted to 2.09 Å resolution from a reservoir 
containing 0.1 M HEPES:NaOH (pH 7.0) and 30% (v/v) Jeffamine (O,O’-Bis(2-
aminopropyl)polypropylene glycol-block-polypropylene glycol). All crystallizations were 
conducted at room temperature (21 ºC).  
 
2.7. Data Collection & Processing of Apo-HP0175  
Initial diffraction screening of crystals was performed on a Rigaku MicroMax-007 HF 
rotating anode X-ray generator with Saturn 944+ CCD detector. Data collected here consisted of 
100 images at a crystal-to-detector distance of 60.0 mm, 20 s exposure time with angles 285-346°. 
Once diffraction confirmed the presence of a protein crystal, the samples were sent to the Canadian 
Macromolecular Crystallography Facility (CMCF) located at the Canadian Light Source (CLS) in 
Saskatoon, Canada. At the CMCF, the 08ID-1 beamline was used with a Pilatus 6M detector, 200 
mm distance, exposure time set to 0.3 s, 𝜆 = 0.979 Å, covering an angular range of 0-180° to a 
total of 900 frames (0.2° per image). Images collected were indexed, refined and integrated 
operating XDS.117,118 Space group analysis and data reduction was performed by 






2.7.1. Structure Solution & Refinement 
The structure of apo-HP0175 was solved by molecular replacement using PHASER122 
through PHENIX.123 Inhibited HP0175 bound to indole 2-carbocylic acid (I2CA) was used as the 
search model for molecular replacement. The search model was fragmented into three regions; 
PPIase domain (residues 151-257) and the N-terminal helices (residues 54-98 and 105-130) 
represented in Figure 2.1. Autobuild (rebuild in space)124 was performed in PHENIX123 for 
positioning of the model based on electron density. The structure was further manually re-built in 
COOT125 using 2FOFCWT and PH2FOFCWT maps and refined with REFMAC in the CCP4i121 
program suite interface. The final refined structure contains amino acid residues 43-60 and 
residues 69-299, with only one break in the structure for the missing residues 61-68; no electron 
density was observed prior to residue 43 and therefore these amino acid residues are not included 
in the final refined structure. The final refined structure and structure factors were deposited in the 
Protein Data Bank with accession code 6BHF. 
 
Figure 2.1. Molecular replacement model. The PPIase domain is represented in mauve (151-
257 aa), helix (105-130aa) is colored blue, and yellow represents helix with residues 54-98aa. 





2.8. Electrospray Ionization Mass Spectrometry 
Mass spectrometry has become a sensitive bioanalytical method for studying biological 
samples.127 Mass spectrometry separates analytes in the gas phase through a mass to charge ratio. 
Solution phase can be directly coupled to the electrospray ionization (ESI) source, where ions are 
produced upon passing through a capillary with electric potential between 2-6 kV. This high 
electric potential generated at the tip of the capillary produces a dispersion in the sample, creating 
a Taylor cone.128 Due to the electrically conductive liquid, shape altercation is through surface 
tension and the electric field becomes prominent upon increasing capillary voltage.128 Once the 
solvent is evaporated and sprayed, the ions travel to the mass analyzer that separates based on 
mass-to-charge (m/z) ratio. Both positive ion mode and negative ion mode can be used to asses 
proteins;128 the positive ion mode was used for analysis of apo-HP0175. Instrument settings used 
for the analysis of HP0175 with ESI-MS includes; capillary voltage 2.8 kV, sampling cone 80.0, 
extraction cone 2.0, source temperature 120 ˚C, desolvation temperature 150 ˚C, cone gas flow 30 
L/Hr, nanoflow 1.0 Bar, desolvation gas flow 500.0 L/Hr, trap collision energy 15.0, transfer 
















Chapter 3: Results and Discussion 
3.1. Cloning ∆KB7 and ∆P1 into pGEX-4T2 
The pilins explored in this study were truncated (∆1-28) KB7 and P1 extracted from the 
pMAL-p2 plasmid vector (lab stocks). Expression in pMAL-p2 contained the periplasmic 
expression of maltose binding protein (MBP) tagged to ∆KB7 and ∆P1. Column cleavage of MBP 
is not recommended due to the large amount of Factor Xa required, as well as the duration 
associated, estimating 5% cleavage for 24-48 hours.129 Secondary MBP purification with an 
amylose column is not amenable because MBP after elution contains maltose, not removable with 
dialysis and therefore cannot bind to the amylose column again.129 Ion exchange is not ideal 
associated with the close isoelectric points of MBP and KB7 (5.2 and 4.5, respectively), while high 
resolution size exclusion chromatography would induce oligomerization of the pilin (GF Audette; 
personal communication). Therefore, a different expression system is required for ∆KB7 and ∆P1. 
The truncated pilins of KB7 and P1 were PCR amplified from pMAL-p2 plasmid vector and were 
successfully cloned into pGEX-4T2 vector (Figure 3.1 and 3.2). Amino acid sequences of ∆KB7 









Figure 3.1. PCR products of ∆P1 and ∆KB7. The products were introduced onto a 2% agarose 
gel and viewed with UV light. (A) ∆P1 was PCR amplified with primers P1_forward and 
P1_reverse lanes 1-4. (B) Representation of pGEX-4T2 plasmid vector double digested with XhoI 
and EcoRI-HF lanes 1-7. (C) PCR amplicon of ∆KB7 achieved with primers KB7_Forward and 
KB7_Reverse lanes 1-4.  
 
(A) (B) (C) 
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3.2. GST-∆KB7 and -∆P1 Sequence Analysis 
Prior to sequencing the cloned constructs of ∆KB7 and ∆P1 in the pGEX plasmid, they 
were gene extracted and double digested with EcoRI and XhoI. Digestion of the plasmid with the 
required restriction enzymes verified presence of ∆KB7 and ∆P1 genes within the 500-base pair 
region. Figure 3.2 represents successful placement of the ∆KB7 and ∆P1 genes and was 









Figure 3.2. Verification of cloning through restriction enzyme double digest. (A) 1,3 and 5: 
pGEX plasmid double digested with XhoI and EcoRI-HF contained ∆KB7 gene. 2; pGEX EcoRI-
HF digestion. 4 and 6: pGEX XhoI digestion. (B) 1: pGEX plasmid with ∆P1gene. 2: pGEX 
plasmid with ∆P1 gene, double digested with XhoI and EcoRI-HF. 
 
3.3. GST-∆KB7 and ∆P1 Expression Trials 
Expression trials were performed to determine the optimal temperature and broth at which 
GST-∆KB7 growth was favoured. It was observed that GST tagged proteins contained a leaky 
expression, which should be further optimized. From Figure 3.3.1; the best conditions for 
expression are that of 3.5 hours/37 °C in LB with induction, as well as the expression in TB/37 °C 
with induction. However, since TB contains more components, the most economical choice 
remains in expressing with LB media. Expression trials for GST-∆P1 in LB are represented in 
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Expression trails against TB media are not represented here. While optimal expression of GST-
∆P1 is observed at 37°C/2 hours with IPTG induction. 
 
 
Figure 3.3.1. Expression trials of ∆KB7 expressed with GST tag in E. coli BL21 (DE3). a) 1) 
32°C, 0 hrs in LB. 2) 32°C, 0 hr in TB. 3) 37°C, 0 hr in LB. 4) 37°C, 0 hr, in TB. 5) 32°C, 1 hr, 
uninduced in LB. 6) 32°C, 1 hr in TB, induced. 7) 37°C, 1 hr, uninduced in LB. 8) 37 °C, 1 hr, 
induced in LB. b) 9) 37°C, 2 hr, induced in TB. 10) 37°C, 2 hr, induced in LB. 11) 32°C, 2 hr, 
induced in TB. 12) 32°C, 3 hr, induced in TB. 13) 37°C, 3 hr, induced in TB. 14) 37°C, 3 hr, 
induced in LB. 15) 32°C, 3.5 hr, induced in LB. 16) 37°C, 3.5 hr, induced in LB. 17) 37°C, 3.5 hr, 
induced in TB.   
 
Figure 3.3.2. Expression trials of ∆P1 expressed with GST tag in E. coli BL21 (DE3). Different 
temperatures were used in LB media. 1) 0 hr. 2) 32°C, induced at 1 hr. 3) 32°C, un-induced, 1 hr. 
4) 37°C, induced, 1 hr. 5) 37°C, un-induced, 1 hr. 6) 32°C, induced, 2 hr. 7) 32°C, un-induced, 2 
hr. 8) 37°C, induced, 2 hr. 9) 37°C, un-induced, 2 hr. 10) 32°C, induced, 3 hr. 11) 32°C, un-
induced, 3 hr. 12) 37°C, induced, 3 hr. 13) 37°C, un-induced, 3 hr. 14) 32°C, induced, 4 hr. 15) 
32°C, un-induced, 4 hr. 16) 37°C, induced, 4 hr. 17) 37°C, un-induced, 4 hr. 18)16°C, induced, 16 
hr.  
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3.4. Purification of GST-∆KB7 and GST-∆P1 
 Isolation of GST-∆KB7 was achieved using batch purification utilizing a glutathione resin, 
which allowed an additional period for binding. This was the optimal method in comparison to the 
ÄKTA purifier, as it resulted in half of the protein eluting in the flow through. The supernatant 
(Figure 3.4A) was syringe filtered and incubated on column for a total of 1 hour before elution 
(loading buffer: 50 mM Tris pH 8.0, 150 mM NaCl and 1mM PMSF). Fractions 1-10 (Figure 3.4B) 
were pooled and concentrated utilizing a 30 MWCO Millipore concentrator (Figure 3.4C). Large 
amounts of the GST tag passed through the 30 MWCO membrane, thereby providing for a cleaner 
sample in comparison to the MBP tagged protein. Purification of GST-∆P1 was not successful in 
producing a clean and concentrated protein of interest. Purification of ∆KB7 with a GST tag (25 
kDa) in comparison to the MBP (45 kDa) indicated that a larger tag is required to solubilize the 
protein of interest. This was observed with the amount of protein lost in the pellet after sonication 





Figure 3.4. Purification of ∆KB7. Fractions demonstrated on a 12.5% SDS PAGE. (A) Pellet (1), 
supernatant (2), Flow through from purification (3), cell pellet after sonication (4). (B) Fractions 
1-10 represent eluted GST-∆KB7 in 10 mM Tris and 10 mM glutathione (pH 8.2). (C) 




























3.5. Crystallization of GST-∆KB7 
Crystallization of GST-∆KB7 was arranged using sitting drop vapour diffusion with 5-15 
mg/ml protein densities. The crystallization suites used for initial screening were JCSG + core 
(Qiagen), MCSG II, IV and Top96 (Anatrace). Several successful conditions were achieved 
(Figure 3.5), however, only one crystal was diffracted (Figure 3.5A and 3.6). The conditions 
achieved did not contain cryoprotection, and therefore further optimization is required. With the 
tools available, 0.2% bromothymol blue dye was added to the droplet containing the crystal to 
observe colour change. Packing of salt crystals are very constricted and does not allow dye to 
penetrate. Since protein crystals contain roughly 20-50% solvent, they allow dye to diffuse and 
can be used as a technique to distinguish protein crystal from non-protein.  
 
 
Figure 3.5. Crystallization conditions achieved for GST-∆KB7. Buffer conditions; (A) 2.0 M 
Ammonium sulfate, 0.2 M Sodium chloride, 0.1 M Sodium cacodylate pH 6.5. (B) 3.2 M 
Ammonium sulfate, 0.1 M Citric acid pH 4.0, final pH of 5.0. Crystal represented in (B) was 
stained in (C) with 0.02% bromothymol blue.   
 
3.5.1. Crystallization Screening  
One of the crystals achieved from Figure 3.5 (A) was screened for diffraction. The 
following crystal was cryoprotected through soaking with increasing concentrations of 
cryoprotectant (glycerol: 10, 15 and 35%). The following did not provide for a protein diffraction 
pattern as only ice rings and small molecule diffraction was observed (Figure 3.5.1).  
 




Figure 3.5.1. Diffraction analysis of GST-∆KB7. The crystal was soaked with increasing 
concentrations of glycerol (5, 10 and 35%). Ice rings and small molecule reflections were observed 
instead of protein diffraction. The detector distance was set to 60 mm with exposure time to 10 s, 
and 0˚ image frame.  
 
3.6.     Expression and Purification of HP0175  
HP0175 was provided in a hexahistidine-tagged construct in the pET28a plasmid by our 
collaborator, M. Kundu of the Bose Institute (Calcutta, India), and was transformed into E. coli 
(BL21) DE3 by a previous lab member. Glycerol stocks of the plasmid in BL21 (DE3) cells were 
stored in 50% glycerol at -80 °C. Optimal expression of HP0175 was determined to be in terrific 
broth for a total of 4 hours with IPTG (1 mM) induction at 32 °C and 200 rpm. Following 
expression, cells were harvested by centrifugation (6,000 x g, 4 °C, 20 min), cell pellets were 
stored at -20 °C for later use. Release of protein (36393.73 Da) from the cell was performed via 
sonication in loading buffer (20 mM HEPES:NaOH pH 7.4 and 500 mM NaCl) and purified on 
ÄKTA Purifier 10S (GE Healthcare) using Nickel Immobilized Affinity Chromatography 
(IMAC). HP0175 was eluted with 35% (7 mM HEPES:NaOH pH 7.4, 175 mM NaCl and 35 mM 
Imidazole) elution of linear gradient (Figure 3.6). Fractions containing HP0175 were pooled and 
buffer exchanged into 10 mM HEPES:NaOH (pH 7.4) with dialysis overnight. Since purification 
of HP0175 produced a large amount of protein, excess was stored at -80 °C with 50% glycerol. 






















Figure 3.6. IMAC purification of HP0175. (A) IMAC chromatographic profile for the 
purification of HP0175. Blue line represents the absorbance of proteins at 280 nm, while the linear 
green line represents the elution profile of the buffer. The first peak shows different proteins 
expressed by the bacteria binding to the column between 0-100 ml. HP0175 elutes at 35% which 
represents fractions 8-12 in 7 mM HEPES pH 7.4, 175 mM NaCl and 350 mM imidazole. (B) 
12.5% SDS PAGE; pellet after sonication (lane 1), supernatant for purification (lane 2), flow 
through fractions (lanes 3-5), elution of peak 1 from purification chromatogram in (A) is 
demonstrated in fractions 6 and 7, fractions from peak 2 beginning from 250 ml are in lanes 8-12, 
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3.7. Crystallization of HP0175 
Crystallization trials were prepared as per Section 2.6 and 2.7 using vapour diffusion sitting 
drop and hanging drop geometries, for screening and optimization, respectively. Initial 
crystallization plates were arranged with densities varying between 5-25 mg/ml (0.75 𝜇L protein 
and 0.75 𝜇L buffer content), using the MCSG I-III crystallization suites. A promising crystal was 
obtained from reservoirs of 0.1 M Tris:HCl pH 8.5 and 2.5 M ammonium sulfate (Figure 3.7A); 
however this crystal was not cryoprotected, therefore further optimization was obligatory. Upon 
optimization, spherulites (Figure 3.7B) were observed which presented the opportunity for 
microseeding. Microseeding trials were performed with the spherulites of dilutions 1:10, 1:100, 
1:1000 and 1:10000, the seeds were applied at different stages of protein and buffer incubations, 
plates were equilibrated and allowed to reach saturation over the course of 24 and 48 hours, this 
also ensured the seed added would not dissolve. A crystal seed diluted by 1:1000 was added after 
48 hours of equilibration, which provided a large crystal (Figure 3.7C) in 0.1 M Tris:HCl, 47.4 % 
ammonium sulfate and 7 % (w/v) PEG 3350. Conversely, this crystal did not provide for a solvable 
diffraction pattern at 7.8 Å (Figure 3.7.1A). The condition in Tris:HCl (Figure 3.7C) yielded a 
poorly diffracting crystal, but provided a thorough estimate of crystallization concentration. 
HP0175 was re-screened against fresh crystallization buffers MCSGI-III suite buffers; a diffraction 
quality crystal was obtained. This crystal was observed to diffract to a resolution of 2.3 Å (Figure 



























Figure 3.7. Crystallization of HP0175. (A) Initial crystal achieved with 14.5 mg/ml protein 
sample in MCSG-II (condition H11) comprising of 0.1 M Tris:HCl pH 8.5 and 2.5 M ammonium 
sulfate, discovered 9 days after plating. (B) Spherulite achieved with optimization plate in hanging 
drop vapour diffusion, condition consisted of 0.1 M Tris-HCl pH 8.4, 43.1 % ammonium sulfate 
and 7.5% (w/v) PEG 3350.  The following condition was obtained based on the crystal in (A). (C) 
Hanging drop vapour diffusion obtained from microseeding with (B); 0.1 M Tris:HCl pH 8.3, 
47.4% ammonium sulfate and 7.5% (w/v) PEG3350. (D) Re-screening of HP0175 with 16.7 mg/ml 
in fresh MCSGII crystallization suite, condition: 0.1 M HEPES:NaOH (pH 7) and 30% (v/v) 
Jeffamine, also known as O,O’-Bis(2-aminoprolyl)polypropylene glycol-block-polypropylene 
glycol.  
 
3.7.1. Diffraction Analysis  
The HP0175 crystal obtained from microseeding (Figure 3.7C) diffracted to 7.8 Å (Figure 
3.7.1A) at the synchrotron. While further screening achieved with MCSG-II suite diffracted to 2.3 





of the data indicated the highest diffraction resolution was not 1.8 Å, but rather 2.09 Å due to poor 




Figure 3.7.1. Diffraction images for HP0175 crystals. (A) CMCF 08B1-1, detector distance set 
to 400 mm, 3 s exposure time, 90°, indicated a resolution of 7.8 Å. (B) Diffraction acquired on 
Rigaku Micro-Max 007 HF, resolution range 29.96-2.3 Å, exposure time 20 s at 286°. (C) CMCF 
08ID-1 beamline, pilatus 6M detector, 200.00 mm distance, 0.3 s exposure, 4°, comprising a 
resolution range of 48.48 - 2.09 Å.  
 
The initial space group identified from the diffraction data (both on the home source and 
beamline data) was determined to be P3121. Upon phasing via molecular replacement, the 
enantiomeric space group P3221 was determined as the appropriate space group, therefore the 
diffraction data was re-processed accordingly using P3221. Images were indexed utilizing XDS-
GUI,117 scaled and merged by the Pointless/Aimless/cTruncate routine119 (Table 3.1) in the CCP4 
program suite.121 Molecular replacement was performed with Phaser122 followed by Autobuild 
routine in PHENIX;123 the model was rebuilt with Coot125 and refined by Refmac. Merging 
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Table 3.1. Merging statistics for diffraction data 
 081D-1 Beamline, CLS 
Space group P 32 2 1 
Wavelength (Å) 0.979 
Resolution Range (Å) 48.48 - 2.09 (2.14 - 2.09) 
Unit cell parameters (Å, °) a=b= 90.95, c = 67.05 
 α = 𝛽 = 90 and γ = 120 
Total number of observations 190,760 (14742) 
No. of unique reflections 19446 (1459) 
Completeness (%) 99.9 (99.5) 
Average I/σ(I) 15.2 (1.5) 
Rmeas (all I+ & I-) 0.088 (1.690) 
Rmergea 0.084 (1.604) 
CC1/2 0.999 (0.786) 
B Wilson (Å2) 42.5 
Multiplicity 9.8 (10.1) 
Mosaicity (°) 0.33 
    *Brackets contain highest resolution shell (2.14-2.09 Å)  
        aRmerge = ∑ ∑ (N< 𝐼Q > −𝐼Q,TN/ ∑ ∑ 𝐼Q,T)TQTQ , where h represents unique reflections, i       
      depicts their symmetry equivalent 
 
Table 3.2. Summary of refinement statistics 
Resolution range (Å) 45.48-2.09 
Reflections used 18461 
Completeness for range (%) 99.9 
Rworkb 0.217 
Rfreec 0.275 
Average B-factors (Å2) 61.78 
No. of atoms 2061 
Water 57 
Ramachandran Plot (%)  
Favoured 98.0  
Allowed 2.0  
 
bRwork = ∑ V𝐹XYZℎ𝑘𝑙| − N𝐹^_`^ℎ𝑘𝑙V/∑ N𝐹XYZℎ𝑘𝑙NQa` 	Qa`  






Figure 3.7.2. Ramachandran plot for HP0175 model building. Number of residues in favoured 
region (~ 98.0% expected): 240 (98.0%). Number of residues in allowed region (~2.0% expected): 







Figure 3.7.3. Ramachandran plot for specific residues in HP0175. Number of residues in 
favoured region (~ 98.0% expected): 240 (98.0%). Number of residues in allowed region (~2.0% 





3.7.2. Overall Structure of Apo-HP0175 
We have crystallized the apo form of the peptidyl-prolyl cis,trans-isomerase HP0175 to a 
resolution of 2.09 Å in the space group P3221, with one monomer in the asymmetric unit. The 
overall monomeric structure of apo-HP0175 comprises three domains, the PPIase domain and the 
N- and C-terminal helical chaperone domains (Figure 3.7.5A). The N- and C-terminal 𝛼-helical 
chaperone domains are between residues 75-97 (𝛼1), 104-132 (𝛼2) and 261-292 (𝛼8), respectively. 
The conserved PPIase domain is located between residues 151-257 and is represented by 𝛽-strands 
(𝛽3, 𝛽4 and 𝛽5) enclosed within four helices (𝛼4, 𝛼5,	𝛼6 and 𝛼7). Respectively, the overall 
monomeric shape of HP0175 resembles that of an asymmetric dumbbell. In addition to the helices 
of the N- and C-terminal domains, 𝛽-strands are located in residues 45-49, 51-53 and 295-297 
(Figure 3.7.5A). The linker region Loop 1 (98-103 aa) connects helices 𝛼1 (75-97 aa) and 𝛼2 (104-
132 aa) facilitating stabilization of the helices. Within the first turn, hydrogen bonding is observed 
between the carbonyl of the main chain of Ala95 (𝛼1) and main chain amide of Leu100 (Loop1). 
Within Loop 1, stabilizing H-bonds are observed between the main chain carbonyl of Lys99 and 
amide backbone of Asp101 (3.18 Å). Thr103 contains two important interactions, the first interface 
is within Leu100 of loop 1 (main chain; carbonyl) and the second with Lys107 of 𝛼2 (main chain; 
amide), H-bond interactions measured as 2.95 Å and 2.89 Å, respectively.  
Parvulin-type PPIases are classified as domain-swapped dimeric proteins, observed via the 
structures of cjPEB4,98 BsPrsA,99 and EcSurA.100 Apo-HP0175 was crystallized in the space group 
P3221 with one monomer in the asymmetric unit. We therefore sought to understand if HP0175 
was a monomer or dimer prior to binding a target molecule (such as I2CA), initially through size 
exclusion chromatography (SEC). SEC analysis of HP0175 was however inconclusive in 
determining monomeric or dimeric state of the protein (not shown) with multiple overlapping 
species being present, which is likely attributable to the extended N- and C-terminal chaperone 
domain helices of HP0175 increasing interactions with the SEC matrix versus that of a more 
globular protein. A similar abnormal SEC separation has previously been observed in PEB4, a 
parvulin-like PPIase with 34.5% sequence identity to HP0175,98 where the protein was observed 
to elute abnormally through interaction with the SEC matrix.98 We therefore explored electrospray 
ionization mass spectrometry (ESI-MS) in order to provide further insight into the potential 
monomeric or dimeric state of apo-HP0175 in solution. Interestingly, the ESI-MS spectrum 
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observed for apo-HP0175 in 10 mM ammonium acetate (Figure 3.7.4) indicated both monomeric 
and dimeric species with differing mass to charge (m/z) distributions being present. Indeed, three 
(3) species are observed:  monomeric protein between m/z 2000-3000 and +12 to +20 charge, 
dimeric HP0175 at m/z 3700-4700 and +16 to +20 charge, and unfolded protein observed between 
m/z 1000-5000 and +21 to +31 charge. Under these conditions, the monomeric form of the protein 
ionizes at a much more significant rate in comparison to the dimeric form of the protein. The 
average molecular masses observed for the monomeric and dimeric species of HP0175 were 
36,421.85 Da and 72,945.27 Da, respectively; a molecular mass of 35,252.25 Da was also observed 
in ESI-MS experiments, which can be associated to an HP0175 monomer following the loss of the 
hexahistidine purification tag. 
 
 
Figure 3.7.4. Electrospray ionization mass spectrum of apo-HP0175. ESI-Mass spectrometry 
chromatogram on native HP0175 in 10 𝜇M Ammonium acetate pH 8.1 (NH4:Cl). A high range of 
charge distribution is observed for the monomeric HP0175, ranging between +11 and +34 charge 
states (1000-3000 m/z), providing an average molecular weight of 36,421.85 Da. A lower 
molecular weight was also observed, calculated to be 35,252.25 Da (2000-3000 m/z). The dimer 
representation shows a structured protein in comparison to the monomer, charge states between 
+16 to +20, averaging the dimeric molecular weight to 72,945.27 Da. 
 
These observed masses from ESI-MS are different from what was observed in the final 
refined structure of the protein. While the mass observed in ESI-MS indicated the presence of all 
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residues at the start of crystallization, in the final refined structure, only residues 43-60 and 69-
299 could be modeled within electron density maps. The original pET28a expression vector 
expressed a protein of 322 residues, as observed in ESI-MS, and consists of 10 amino acids for the 
purification tag and 299 residues of the complete HP0175 gene; of these 299 residues is a predicted 
21 aa N-terminal signal peptide (as predicted by SingalP).131 It is therefore likely that these 31 
residues were auto-catalytically removed during the time course of crystallization, resulting in a 
crystallized protein that spanned residues 22-299, of which the noted residues were observed in 
the electron density. It is interesting to note that the HP0175 construct used in the determination 
of the I2CA-bound protein (PDB ID 5EZ1; Naveen et al., 2016)97 was cloned to span residues 33 
to 299 of the protein with a C-terminal hexahistidine purification tag. The authors indicated that 
their construct represented the protein following the removal of the signal peptide,97 although the 
predicted signal peptide cleavage is between residues 21-22, their final model consists of residues 
54-61 and 74-296.97 
The dimer representation of apo-HP0175 was generated with a symmetry related monomer 
(X-Y, -Y, -Z+1/3), in reference to the first monomer in coordinates (X, Y, Z) represented in Figure 
3.7.5B. Stabilization of the homodimer is through intertwining of the NC 𝛼-helices and the 
hydrogen bonding between N-terminal 𝛽-strand 1 (aa 45-49) of the (X, Y, Z) monomer and the C-
terminal 𝛽-strand 6 (aa 295-297) of the symmetry mate. Specifically, hydrogen bonding is 
observed between the backbones of Asp49 and Lys294, Thr47 and Val296, Leu45 and Ile297, 
Val44 and Asn298. Examination of the thermal factors (Bav) for 𝛽-strands 1, 2 and 6 indicate that 
Bav for 𝛽-strand 1 and 6 were 59.2 and 53.8 Å2 respectively, while 𝛽-strand 2 was determined as 
70.4 Å2. The differences in thermal Bav calculated, further support that homodimer is stabilized by 
the interaction between 𝛽-strand 1 and 6; 𝛽2 is not similarly stabilized, rendering it slightly more 










Figure 3.7.5. Monomeric and dimeric forms of apo-HP0175. (A) The apo-HP0175 monomer 
observed in the crystallographic asymmetric unit. The monomer consists of three domains; the N-
terminal chaperone domain, composed of β1 (aa 45-49), β2 (aa 51-53), 𝛼1 (aa75-97), and 𝛼2 (aa 
104-132), precedes the PPIase domain (aa 151-257), comprised of four 𝛽-strands (𝛽3, 𝛽4 and 𝛽5) 
enclosed within four helices (𝛼4, 𝛼5,	𝛼6 and 𝛼7), and ends with the C-terminal chaperone domain 
of 𝛼8 (aa 261-292) and β6 (aa 295-297). Connecting loops are shown as L1 (aa 98-103), L2 (aa 
133-136), and L3 (aa 255-261). (B) The HP0175 dimer is generated the symmetry (X-Y, -Y, -
Z+1/3) related monomer (cyan) to that of the (x, y, z) monomer (teal). Stabilization of the dimer 
occurs through intertwining of the N- and C-terminal helices, as well as hydrogen bonding between 𝛽-strands 1 and 6, and specific interactions occurring between main chain atoms of Val44 and 
Asn298, Leu 45 and Ile297, Asp49 and Lys294, Thr47 and Val296. 
 
3.7.3.  Structural Variations Between Apo-HP0175 and I2CA-HP0175  
Target molecule binding in the PPIase domain results in only modest changes (Figure 
3.7.6). The catalytic residues in the PPIase domain (aa 151-257) are His161, Asp199, Met219, 
His161 and His247.97 Superposition of apo-HP0175 and I2CA-HP0175 PPIase domains obtained 
an r.m.s.d of 0.384 Å for 91 Ca atoms (Figure 3.7.6A). Structural alterations directly associated 
with residues interacting with the indole-2-carboxylic acid ligand are Asp199, Met219, Leu211, 
Phe223, Phe244 and His247 were observed (Figure 3.7.6B).97 Specifically, addition of the ligand 
weakened the stabilization amongst His161, His247 and Asp199 (Figure 3.7.6C). The histidine 
residues 161 and 247 had contact distances of 2.9 Å in apo-HP0175 which increased to 3.9 Å in 
𝛽6 𝛽1 𝛽2 
𝛽1 𝛽2 
𝛽4 𝛽3 𝛽5 
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I2CA-HP0175. In relation, His161 and Asp199 increased to 3.4 Å from 2.7 Å in I2CA-HP0175. 
While the sulfur atom of Met219 is positioned closer to the I2CA-phenyl ring with a distance of 





Figure 3.7.6. Superposition of the catalytic site in apo and I2CA bound HP0175. (A) 
Superposition of the PPIase domain in apo-HP0175 (cyan) and I2CA-HP0175 (green) is 
demonstrated by a cartoon figure, where the residues involved in the catalytic pocket is 
demonstrated in sticks. Indole-2-carboxylic acid (inhibitor) is coloured in orange for a clearer 
representation. (B) Apo-HP0175 shows interactions between His 247, His161 and Asp199. (C) 
I2CA-HP0175 demonstrates that interaction between His161 and Asp199 are weakened and 
disrupted between His247 and His161 due to the addition of I2CA, while the sulfur atom is closer 
to the indole ring and methyl group is directed away. (PDB ID I2CA-HP0175: 5EZ1 and 6BHF of 
APO-HP0175). 
 
Previous studies had used cjPEB4 as the structural reference for apo-HP0175 
conformation, elaborating on targeted interaction; PEB4 was a prime candidate for representing 
apo-HP0175 based on 34.5% sequence identity and superposition yielding an r.m.s.d of 3.3 Å for 



















able to compare the dimer conformation of HP0175 in the apo and I2CA bound to further 
extrapolate on structural changes; one noted observation is the opening of the central cavity within 
the dimer. Distances within the central cavity were measured between two Phe143 (𝛼3) and two 
Gln279 (𝛼8) residues, while the distance separating the PPIase domain was measured between 
Gln206 residues between monomers. In the apo-HP0175 structure, the distances were calculated 
as 53.0 Å (𝛼3) and 40.5 Å (𝛼8) for the central cavity, and 47.3 Å for the PPIase domain, 
respectively (Figure 3.7.7A). Binding of I2Ca in the PPIase domain increases the opening in the 
central cavity to 68.1 Å (𝛼3) and 47.8 Å (𝛼8), respectively; binding of I2CA results in a closing 
of the distance between the PPIase domains, halving the distance between each monomeric PPIase 
domain (22.8 Å) (Figure 3.7.7B). 
The structure of native HP0175 and I2CA-HP0175 were determined in enantiomeric space 
groups (P3221 and P3121, respectively) from slightly different crystallization conditions, though 
they diffract to similar resolutions and have similar solvent contents. The present similarities and 
differences in the two structures allow for the comparison of thermal factors in certain domains 
(Table 3.3) in support of observed structural differences between the two structures. Thermal 
factors (Bav or B-value) are based on the static dynamic motion of atoms within the crystal and 
respectively determine contouring of the electron density map.132 For the purpose of the current 
comparison, each domain was arranged from low to high Bav values found in one crystal. The 
domains are then compared to the same domains within the second crystal and/or second monomer 
to identify any significant changes. This is performed as an indirect way to standardize the 
measured values in each crystal. In addition, crystal packing of the two structures resembled 
similar contacts, therefore the thermal factors analyzed are not a result of variances in packing 








Figure 3.7.7. Comparison of apo-HP0175 and I2CA-HP0175. (A) Symmetry generated dimer 
of apo-HP0175 in comparison to dimeric I2CA-HP0175 (B). (C) Superposition of monomeric apo 
and I2CA-HP0175; anchored at the PPIase domain to demonstrate the extension of helix 𝛼8 from 
the apo (cyan) to I2CA (orange)-bound HP0175, red arrow to show the path of extension of helix 𝛼8 from the apo (cyan) to I2CA (orange)-bound HP0175, red arrow to show the path of extension. 
(D) Top-view representation demonstrating the extension of the helices, black arrow shows the 
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Table 3.3. Comparison of Bav valuesa for apo-HP0175 and I2CA-HP0175 
Protomer Label Residues Bav MC Bav Range Bav 
Apo-HP0175   59.0 50.08-92.7 62.0 
Chain A: I2CA-HP0175 a1 75-97 57.0 26.7-117.7 61.0 
Chain B: I2CA-HP0175   64.0 32.8-120.4 67.7 
Apo-HP0175   59.1 52.2-80.4 63.5 
Chain A: I2CA-HP0175 a2 104-132 41.4 31.3-86.7 50.0 
Chain B: I2CA-HP0175   47.1 34.0-86.1 55.5 
Apo-HP0175   55.5 48.7-71.3 58.6 
Chain A: I2CA-HP0175 L3 255-262 61.3 35.6-69.0 59.4 
Chain B: I2CA-HP0175   82.1 69.8-104.1 82.0 
aBav values are provided in Å2, Main Chain (MC) 
 
The comparison of B-values between apo- and I2CA-bound in the current study is based 
on a similar report by Edwards and colleagues;77 in this study, thermal factors from the structures 
of E. coli cytoplasmic peptidyl-prolyl cis,trans-isomerase (EcoCyPA) bound with a tripeptide 
substrate succinyl-Ala-Pro-Ala-p-nitroanilide and in its unliganded form were compared. The 
study compared protein crystals grown in different crystallization conditions and space groups; 
C2221 and P212121 for the uncomplexed and complexed EcoCyPA, respectively. The authors 
stated that comparison of crystal structures in two different space groups provides more insight on 
how a structure may behave in solution, and comparison of the two structures determined similar 
overall conformations, the regions compared were those involved in ligand binding.77 Within a 
crystal structure, an analysis of the B-values is a means to assess the regional thermal motion; this 
analysis can only be applied for thermal motion within particular regions of the protein, rather than 
as a metric for the protein as a whole, as crystal contacts may affect thermal motion of loops, 
helices or 𝛽-strands. Additionally, thermal factors can be compared across different protein-DNA 
structures through normalization of B-factors by unity-based scaling or z-score normalization, as 
demonstrated by Schneider et al., 2014.132 Since apo- and I2CA-bound HP0175 were of similar 
overall structure, and crystallized in enantiomeric space groups to similar diffraction resolutions, 
it was unnecessary to scale the B-factors. A more in-depth analysis of the protein’s dynamics in 
the apo- and ligand-bound states to compliment the thermal factor analysis presented herein could 
be undertaken through Hydrogen Deuterium Exchange Mass Spectrometry or heteronuclear 




Analysis of the N-terminal helices demonstrated 𝛼1 helix is extended by 6.6° from apo to 
the I2CA-bound conformation (Figure 3.7.7D), measured between Lys74 (𝛼1), Thr97 (𝛼1) and 
Asp101 (Loop 1). In the apo-HP0175 structure, helices 𝛼1 and 𝛼2 contained similar Bav values of 
62 Å2 and 63.5 Å2, indicating helix 𝛼1 contained a higher rigidity in comparison to 𝛼2. However, 
the small difference between the two Bav values is not significant and can therefore be concluded 
that both 𝛼1 and 𝛼2 are equally variable. The reverse is observed with I2CA-HP0175, where the 𝛼1 helix contained thermal factors of 61 Å2 in Chain A and 67.7 Å2 in Chain B, while the 𝛼2 helix 
contained a Bav of 50 Å2 (Chain A) and 55.5 Å2 (Chain B). Increased rigidity of the 𝛼2 helix can 
be explained by	𝛼1 extension, inferring once helices are extended, 𝛼2 is forced into a locked 
configuration.  
The differences observed in/near the PPIase domain show increased thermal factors in 
Loop 3 with 59.4 and 82.02 Å2 for chains A and B of I2CA-HP0175, respectively, whereas in apo-
HP0175 the Bav in loop 3 is 58.6 Å2. From this comparison, we can infer upon the effect of ligand 
interaction through the changes noted with residues His161, His247, Asp199, Met219 and Phe244 
subsequently increasing thermal motion in Loop 3 (aa 255-261).97 Increased thermal motion can 
be hypothesized to induce the extension of the C-terminal 𝛼8 helix by 7.4° from apo to I2CA-
HP0175, measured between Glu287 (𝛼8), Tyr262 and Lys254 (PPIase) (Figure 3.7.7C). Extension 
of the N- and C- terminal helices in ligand interaction of HP0175, supports the hypothesis of 
stabilizing protein undergoing catalysis through protein-protein interactions.  
The thermal factors between helices 𝛼1 and 𝛼2 and Loop L3 of apo-HP0175 and I2CA-
HP0175 were also compared. In order to assess if differences in structures were attributable to 
crystal contacts, we reviewed the symmetry mates associated with these regions (Tables 3.4-3.6). 
Within the N-terminal helices in apo-HP0175, only one symmetry contact was observed within 𝛼2 
helix; Lys131 and symmetry related Thr166 of the PPIase domain. The thermal factors associated 
with 𝛼1 (62.0 Å2) were only slightly lower than 𝛼2 (63.5 Å2), even though 𝛼1 did not contain any 
symmetry related crystal contacts. Bav values of the N-terminal helices 𝛼1 and 𝛼2 in the I2CA 
bound HP0175 shows a similar pattern, in Chain A; 𝛼1 and 𝛼2 are calculated as 61.0 Å2 and 50.0 
Å2. In Chain B; the thermal factors were similar and measured as 67.7 Å2 and 55.52 Å2 for 𝛼1 and 𝛼2. In both chains A and B, crystal symmetry contacts are observed in Thr97, Chain B contains 
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an additional symmetry contact involving 𝛼2 (Glu111 — Lys294), however this does not change 
the outcome of both Chain A and B thermal values.  
Apo-HP0175 loop L3 (aa 255-261) shows one symmetry related interaction with Ser256 
to Asp83 (-X, -X+Y, -Z+2/3) with a B average of 58.6 Å2 (range: 52-70 Å2). While the I2CA-
HP0175 chain A contained 2 symmetry related crystal contacts between Ser256 to symmetry 
contact Thr231 and Pro232, the thermal factor associated with loop 3 was 59.4 Å2, while Chain B 
did not contain any symmetry related crystal contacts, and a Bav of 82 Å2. Although chain B did 
not contain any symmetry related crystal contacts, chain A contained 2 symmetry related crystal 
contacts, however, the thermal factor remained relatively higher based on the range of 21-94 Å2 
(Chain B). 
Table 3.4. Apo-HP0175 symmetry crystal contacts 
Contact residue to symmetry related contact Symmetry Operator Distance (Å) 
Val44 (O) — Asn298 (ND2)  X-Y, -Y, -Z+1/3 2.99 
Leu45 (O) — Asn298 (N) X-Y, -Y, -Z+1/3 2.92 
Thr47 (N) — Val296 (O) X-Y, -Y, -Z+1/3 3.02 
Thr47 (O) — Val296 (N) X-Y, -Y, -Z+1/3 3.19 
Asp49 (N) — Lys294 (O) X-Y, -Y, -Z+1/3 2.80 
Asp49 (OD1) — Lys294 (N) X-Y, -Y, -Z+1/3 2.68 
Lys131 (O) — Thr166 (OG1) -Y, X-Y, Z+ 2/3 2.83 
Lys154 (N) — Glu287 (OE1) -X+Y, -X, Z+1/3 2.66 
Thr166 (OG1) — Lys131 (O)  -X+Y, -X, Z+1/3 2.83 
Glu243 (OE2) — Lys148 (NZ) -Y, X-Y, Z+2/3 2.54 
Lys254 (O) — Ile297 (N)  -X+Y, -X, Z+1/3 3.03 
Ser256 (OG) — Asp83 (OD1) -X, -X+Y, -Z+2/3 2.43 
Lys270 (NZ) — Asp168 (OD2) -Y, X-Y, Z+2/3 3.10 
Gln274 (NE2) — Asp168 (OD2) -Y, X-Y, Z+2/3 3.07 
Lys294 (N) — Asp49 (OD1)  X-Y, -Y, -Z+1/3 2.68 
Lys294 (O) — Asp49 (N) X-Y, -Y, -Z+1/3 2.80 
Val296 (O) — Thr47 (N) X-Y, -Y, -Z+1/3 3.02 
Val296 (N) — Thr47 (O)  X-Y, -Y, -Z+1/3 3.19 
Ile297 (N) — Lys254 (O) -Y, X-Y, Z+2/3 3.03 
Asn298 (N) — Leu45 (O) X-Y, -Y, -Z+1/3 2.92 
Asn298 (ND2) — Val44 (O) X-Y, -Y, -Z+1/3 2.99 








Table 3.5. I2CA-HP0175 symmetry crystal contacts for Chain A 
Contact residue to symmetry related contact Symmetry Operator Distance (Å) 
Thr97 (O) — Thr97 (OG1) (B) -X, -X+Y, -Z+1/3 2.77 
Gln150 (NE2) — Glu167 (OE1) (B) X, Y, Z 2.22 
Gln150 (NE2) — Tyr246 (OH) (B) X, Y, Z 3.10 
Asp178 (O) — Tyr262 (N) (A) Y, X, -Z 2.87 
Lys182 (N) — Glu263 (OE2) (A) Y, X, -Z 3.01 
Asn194 (ND2) — Gln206 (OE2) (A) Y, X, -Z 2.99 
Arg195 (O) — Arg195 (NH1) (A) Y, X, -Z 2.98 
Gln206 (OE1) — Asn194 (ND2) (A) Y, X, -Z 2.99 
Ser256 (OG) — Thr231 (OG1) (B) Y, X, -Z 2.91 
Ser256 (N) — Pro232 (O) (B) Y, X, -Z 2.95 
Glu263 (OE2) — Lys182 (N) (A) Y, X, -Z 3.01 
Lys294 (NZ) — Glu111 (OE2) (B) -X, -X+Y, -Z+1/3 3.07 
The letters A and B in brackets refer to the symmetry related to Chain A (A) and Chain B (B) 
 
Table 3.6. I2CA-HP0175 symmetry crystal contacts for Chain B 
 
Contact residue to symmetry related contact Symmetry Operator Distance (Å) 
Thr97 (OG) — Thr97 (O) -X, -X+Y, -Z+1/3 2.77 
Glu111 (OE2) — Lys294 (NZ) -X, -X+Y, -Z+1/3 3.07 
Glu167 (OE1) — Gln150 (NE2) X, Y, Z 2.22 
Thr231 (OG1) — Ser256 (OG)  Y, X, -Z 2.91 
Pro232 (O) — Ser256 (N)  Y, X, -Z 2.95 
Tyr246 (OH) — Gln150 (NE2) X, Y, Z 3.10 
The symmetry contacts relate to Chain A 
 
Coupling the analysis of the structural changes differences in B-values in the regions of 
motion between apo- and I2CA-HP0175 provides insight on the possible function of HP0175 upon 
binding to a substrate. In order to understand the structural differences, both spatially and in terms 
of local thermal motion, we examined the crystallographic contacts made by HP0175 in both 
structures (Tables 3.4-3.6). Although it is natural for proteins to be stabilized through crystal 
packing, no overly influential crystal contacts were observed in with the apo- or I2CA-bound 
HP0175 structures, thereby indicating that the differences observed are not a result of the 
crystalline condition. Therefore, the current analysis of the bound and unbound HP0175 provides 
a better understanding into the possible motions of the protein upon interacting to an inhibitor 
(I2CA-HP0175)97 or other target molecule. It has been suggested that HP0175 binds to TLR4 
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through an immunoassay in Basak et al.50 TLR4 is known to detect bacterial infections through 
the lipopolysaccharide complexed with MD-2 that interacts with the extracellular domain of 
TLR4.133 This interaction may prove to be beneficial in combating H. pylori infections, as HP0175 
could in theory be used as an adjuvant in vaccine design for eliciting an innate immune response.134 
However, more research must be performed into the interaction between HP0175 and TLR4 and 
its effects in vitro prior to development of such approaches. 
 
3.7.4. Comparative Analysis of HP0175 to Other Parvulins  
The parvulin subgroup of PPIases contain similar overall structures as observed in PEB4,98 
PrsA,99 SurA100 and HP0175 (Figure 3.7.8). SurA is a chaperone protein found in Esherichia coli, 
involved in the correct folding of outer membrane proteins (OMPs) and crystallizes with 4 
monomers in the asymmetric unit.100 PEB4, found in Campylobacter jejuni, is a periplasmic 
chaperone that also crystallizes with 1 monomer in the asymmetric unit and the dimer is generated 
through a symmetry-related monomer.98 PrsA is from the gram-positive Bacillus subtilis, and is 
associated with the correct folding of periplasmic proteins requiring export; PrsA crystallizes as a 
dimer in the asymmetric unit.99 These proteins all contain N- and C- terminal 𝛼-helices and the 
catalytic PPIase domain (4	𝛼-helices and 3 𝛽-strands). Dimerization is stabilized by intertwining 
of the N- and C- helices, as well as hydrogen bonding between 𝛽-strands of the N- and C- 
terminals; HP0175, PEB4 and PrsA (Figure 3.7.8). Although the overall structure of these proteins 
is relatively consistent covering a sequence identity between 10-34%, we also see that molecular 
replacement fails for obtaining phases, possibly attributed to the large structural alterations in the 





Figure 3.7.8. The parvulins share a common fold. (A) Apo-HP0175 contains a relatively 
compact overall structure, with crevice dimensions ~22 X 42 Å. (B) SurA the only parvulin 
represented with 2 PPIase domains and is demonstrated as a monomeric species. (PDB ID: 
1M5Y)100 (C) I2CA-HP0175 contains a crevice similar to apo-HP0175, however it is slightly 
larger with dimensions of 55 X 50.7 Å. (PDB ID: 5EZ1)97 (D) PEB4, contains an elongated linker 
connecting to the PPIase domain, when observed as a dimer a large cavity is generated calculated 
to be ~55 X 50 Å. The inner region of crevice is more hydrophobic in comparison to the exposed 
regions. (PDB ID: 3RFW)98 (E) PrsA, slightly more compact between PPIase and NC-domains. 
Inner region of crevice is comparably hydrophobic to the exterior, dimensions were determined as 













The common dimeric conformation of the parvulins contains a crevice that has been 
demonstrated for protein-protein interaction.98,100 Although SurA does not dimerize as seen with 
other parvulins, it maintains a small crevice through the N- and C- helices of the monomer. Another 
feature of parvulins was noted in PEB4 where it inhibited protein aggregation through isolation of 
unfolded proteins; however, this was not observed in PrsA and has not been heavily studied 
amongst all PPIases.98,99 PrsA revealed NC-helix interactions with propeptide AmyE from 𝛼-
amylase B. subtilis through NMR [15N, 1H]-TROSY spectra.99 The different proteins assisted by 
PrsA through correct folding are involved in cell wall metabolism, motility and membrane 
bioenergetics. This feature of parvulins makes them interesting to study especially when chemical 
energy is not required for their function, making them a fascinating target for optimizing protein 
export in biotechnological applications.99 In relation to the proteins presented here, HP0175 is the 
only parvulin crystallized in the apo and liganded form (I2CA-HP0175).97 The two crystal 
structures demonstrate NC domain extensions upon targeted interaction, which infers NC domains 











Chapter 4: Conclusions and Future Work 
4.1. Conclusions  
4.1.1. Peptidyl-prolyl cis,trans-Isomerase HP0175 
The secreted peptidyl-prolyl cis,trans-isomerase HP0175 from Helicobacter pylori (strain 
26695) has been crystallized, and the structure solved to 2.09 Å resolution. Crystallization of 
HP0175 was optimized from 7.8 Å to 2.09 Å resolution, in 0.1 M HEPES: NaOH (pH 7.0) and 
30% (v/v) Jeffamine ED 2001. Native/apo (ligand free) HP0175 crystallizes as one monomer in 
the asymmetric unit of the space group P3221, unit cell dimensions a=b=90.95 Å, c=67.05 Å and 
angles 90˚ and 120˚. The structure was refined to Rwork/Rfree of 21.4 and 27.5 % to a completeness 
of 99.9% for the resolution range 45.48-2.09 Å. Apo-HP0175 was demonstrated as a dimer through 
symmetry generation (X-Y, -Y, -Z+1/3) in reference to (X, Y, Z). Mass spectrometry analysis for 
the molecular weight concluded HP0175 is relatively stable as a dimer in comparison to a wider 
mass-to-charge distribution for the monomer form. The overall structure of the HP0175 monomer 
resembles an asymmetric dumbbell, with N- and C- terminal helices and an extended PPIase 
domain. The dimer shows intertwining of NC domains for stabilization as well as H-bond 
stabilization through 𝛽-strands 1 (N-terminal) and 6 C-terminal of the symmetry generated 
monomer.    
The current report shows the first crystallographic based interpretation of a parvulin 
peptidyl prolyl isomerase in its bound (to an inhibitor) in comparison to the un-bound ‘native’ 
conformation. Previously, interpretations for bound vs. unbound states were demonstrated using 
different tools such as NMR in PrsA with propeptide AmyE,99 SAXS for I2CA-HP017597 and UV-
VIS in PEB4.98 The only documented crystallographic representation of bound and native form of 
peptidyl-prolyl isomerases was demonstrated in E. coli cytoplasmic cyclophilin A (CypA) in the 
native and bound (tri-peptide) conformations.77 Structural comparison of apo-HP0175 and I2CA-
HP0175 PPIase domain shows structural alterations directly associated with residues interacting 
with indole-2-carboxylic acid; Asp199, Met219, Leu211, Phe223, Phe244 and His247. The 
addition of I2CA ligand weakened the interaction between His161, His247 and Asp199, as Asp199 
has an interaction to I2CA indole ring, and the sulfur group of Met219 interacts with the phenyl 
group of I2CA. The global implications of I2CA binding is found with N and C-terminal helices. 
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The N-terminal helix of 𝛼1 was measured to be extended by 6.6° and C-terminal helix (𝛼8) was 
extended by 7.4° from apo to I2CA bound HP0175. The effect of these extensions has a direct 
effect on the crevice within the dimer. The crevice has extended from 53.0 Å (two; 𝛼3) and 40.5 
Å (two; 𝛼8) to 68.1 Å (two; 𝛼3) and 47.8 Å (two; 𝛼8). While the PPIase domain becomes occluded 
upon ligand binding, 47.3 Å to 22.8 Å, which can be extended to include activity of peptide 
binding. 
Since the structure of apo-HP0175 and I2CA-HP0175 were determined in enantiomeric 
space groups and similar resolutions, we analyzed thermal factors (Bav) associated with each 
domain in the two crystals in compliment to the observed structural differences. Only three 
domains demonstrated differences between the two crystal structures, those of 𝛼1 (aa 75-97), 𝛼2 
(aa 104-132) and Loop L3 (aa 255-262). The N-terminal helices 𝛼1 and 𝛼2 support the extension 
of helices forming a rigid and locked configuration upon targeted interaction of the PPIase domain. 
The N-terminal and C-terminal helices are hypothesized to stabilize peptide-protein or protein-
protein interaction, increasing the rigidity of the N-terminal helices supports this theory. While 
Loop L3, the linker between PPIase domain and C-terminal helix 𝛼8, shows a slight increase in 
Bav thermal factors, the increased thermal motion can be hypothesized to induce C-terminal 𝛼8 
helix extension by 7.4° from apo- to I2CA-bound HP0175. This indicates that increased variability 
in Loop 3 may extend the C-terminal helix, and concurrently extend N-terminal helices as well. 
We also notice the occlusion of PPIase domains for further interaction. These structural 
rearrangements in HP0175 can facilitate protein-protein interaction for binding to TLR4 receptor, 
although this remains a focus of on-going study. Thermal factor analysis was performed with 
respect to crystal symmetry contacts present in both crystal structures, acknowledging that a 
fulsome understanding of the motion of a protein on a whole is not achieved with analyzing thermal 
factors alone, rather use of other methods such as NMR or HDX-MS can provide more detailed 
insights in this regard. 
 
4.1.2. P. aeruginosa ∆KB7 and ∆P1 Pilins 
The type IV pilins secreted by P. aeruginosa were successfully cloned into pGEX-4T2 
plasmid. Expression and purification was optimized for GST-∆KB7, however, the expression of 
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GST-∆P1 did not provide pure protein. The expression of GST-∆P1 produced for a leaky 
expression that was only later observed in the purification gel. Crystallization trials for GST-∆KB7 
provided for initial conditions in 2.0 M ammonium sulfate, 0.2 M sodium chloride, 0.1 M sodium 
cacodylate, pH 6.5, and in 3.2 M ammonium sulfate, 0.1 M citric acid, pH 4.0, final pH of 5.0. 
Diffraction analysis for one of the crystals (GST-∆KB7) did not provide for a protein diffraction, 
instead represented ice-ring and small molecule diffraction.   
 
4.2.  Future Work  
4.2.1. Peptidyl-Prolyl cis,trans-Isomerase: HP0175 
The biological function of the chaperone (N- and C-) domains of parvulin PPIases have 
not been extensively studied, and therefore, it would be interesting to explore specific behavior of 
the following domains. Several ways to account for the behavior of the following domains is to 
crystallize HP0175 with extracellular domain of toll like receptor 4 and full-length, as this 
interaction is very important for eliciting immunogenic responses. The following can also be 
further explored utilizing time resolved hydrogen deuterium exchange mass spectrometry. This 
method can highlight the domains within TLR4 and HP0175 interaction. Further understanding of 
the protein can also include interaction studies of HP0175 with a protein that it would catalyze for 
proper folding. This interaction can be studied with mass spectrometry or can mutate several 
residues for suicide inhibition interaction and subsequently crystallize the protein with a peptide 
undergoing isomerization. The following interaction can also be used as a new mode for vaccine 
design, where domains of HP0175 is used for eliciting the innate immunity.  
 
4.2.2. P. aeruginosa: ∆KB7 and ∆P1 
Since cloning of GST-∆KB7 was successful, there remained a reasonable amount of the 
protein found in the pellet after sonication. This could be a result of solubility issues, and therefore 
it would be best to clone the following pilin into a different construct. The ∆KB7 pilin could instead 
be cloned into a cytosolic expression of MBP, with a TEV site for ease of release of the tag, and a 
histidine tag for separation of MBP from ∆KB7 (∆KB7-polyHis-TEV-MBP). As for the 
purification of ∆P1, it should be re-cloned into pGEX-4T2 plasmid, to ensure for a better construct 
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so that it is possible to crystallize with the tag. The ∆P1 pilin has previously been crystallized to 
1.2 Å by Prof. Audette, but structure solution by molecular replacement has proven unsuccessful 
to date (GFA, personal communication). A recent approach has been taken by Üson et al., for 
solving the phase problem through ab initio, based on the tertiary structure of the protein and 
previously solved proteins available.135,136 The following approach was not successful, and thus, 
was not represented in this thesis. Another method in which the phase can be solved for ∆P1 is 
through the mutation of all Leucine residues to Methionine residues.137 The protein lacks 
methionine residues, and therefore, mutating the 6 Leucines in the sequence can provide for a 
phase. Once methionine is present in P1, selenomethionine derivative can be expressed and would 
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Relevant Amino Acid Sequences for Proteins in this Thesis 
Truncated P1  
 
        10         20         30         40         50         60  
ISEFARTQVT RAVSEVSALK TAAESAILEG KEIVSSATPK DTQYDIGFTE STLLDGSGKS  
 
        70         80         90        100        110        120  






Molecular weight= 13034.66 Da 





        10         20         30         40         50         60  
ISEFSRSQVS RVMAEAGSLK TAVEACLQDG RTAVGTAAGQ CDPGATGSSL LTGASQTSQT  
 
        70         80         90        100        110        120  






Molecular weight 12568.90 Da 









Helicobacter pylori (HP0175) with N-terminal Histidine tag 
 
        10         20         30         40         50         60  
MGSSHHHHHH SSGLVPRGSH MASMKKNILN LALVGALSTS FLMAKPAHNA NNATHNTKKT  
 
        70         80         90        100        110        120  
TDSSAGVLAT VDGRPITKSD FDMIKQRNPN FDFDKLKEKE KETLIDQAIR TALVENEAKT  
 
       130        140        150        160        170        180  
EKLDSTPEFK AMMEAVKKQA LVEFWAKKQA EEVKKVQIPE KEMQDFYNAN KDQLFVKQEA  
 
       190        200        210        220        230        240  
HARHILVKTE DEAKRIISEI DKQPKAKKEA KFIELANRDT IDPNSKNAQK WRDLGKFQKN  
 
       250        260        270        280        290        300  
QMAPDFSKAA FALTPGDYTK TPVKTEFGYH IIYLISKDSP VTYTYEQAKP TIKGMLQEKL  
 
       310        320  
FQERMNQRIE ELRKHAKIVI NK 
 
Residues 322 
Molecular weight 36756.13 
Theoretical pI 9.45 
 
Reference: 
Gasteigner E., Hoogland C., Gattiker A., Duvaud S., Wilkins M.R., Appel R.D., Bairoch A. Protein 
Identification and Analysis Tools on the ExPASy Server. (In) John M. Walker (ed): The Proteomics 









Table A. Temperature factors for apo-HP0175 
Label Residue range Bav (MC) Bav (SC) Bav 𝛼1 75-97 59.01 64.31 61.95 𝛼2 104-132 59.11 67.17 63.46 𝛼3 137-151 64.92 73.28 69.44 𝛼4 167-179 57.52 63.97 61.00 𝛼5 182-196 56.84 62.84 60.27 𝛼6 200-205 56.58 63.57 59.91 𝛼7 221-229 59.71 63.47 61.54 𝛼8 261-292 56.69 62.73 61.11 𝛽1 45-48 58.33 59.84 59.18 𝛽2 51-53 67.51 71.95 70.38 𝛽3 156-164 52.07 54.26 53.23 𝛽4 211-215 57.12 49.26 59.58 𝛽5 246-254 52.02 52.98 52.56 𝛽6 295-297 52.74 55.10 53.83 
L1 99-103 65.73 69.13 67.64 
L2 133-136 64.52 68.90 66.75 
L3 152-155 56.40 58.37 57.40 
L4 216-220 69.50 77.44 73.11 
L5 230-245 59.81 57.59 62.68 






























Label Residue range Bav (MC) Bav (SC) Bav 𝛼1 75-97 57.06 62.01 61.03 𝛼2 104-132 41.36 55.65 50.06 𝛼3 137-151 32.40 50.00 42.00 𝛼4 167-179 34.96 46.94 41.78 𝛼5 182-196 18.00 23.97 21.83 𝛼6 200-205 19.75 36.53 28.00 𝛼7 221-229 50.53 48.13 50.45 𝛼8 261-292 37.36 48.11 44.25 𝛽1 55-56 65.40 92.14 85.08 𝛽2 59-60 82.19 107.05 94.62 𝛽3 156-164 23.52 30.00 27.74 𝛽4 211-215 30.26 36.08 35.95 𝛽5 246-254 30.01 35.19 33.80 𝛽6 295-296 84.59 48.16 67.50 
L1 99-103 43.23 45.50 44.30 
L2 133-136 54.90 60.46 58.34 
L3 152-155 45.20 61.77 53.18 
L4 216-220 58.73 67.12 64.21 
L5 230-245 47.68 41.91 47.33 
L6 255-261 61.31 55.97 59.41 
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Table C. Temperature factors I2CA-HP0175 chain B 
Label Residue range Bav (MC) Bav (SC) Bav 𝛼1 75-97 64.07 68.37 67.74 𝛼2 104-132 47.15 61.62 55.52 𝛼3 137-151 95.75 94.53 96.15 𝛼4 167-179 85.22 88.12 87.73 𝛼5 182-196 84.25 80.53 84.91 𝛼6 200-205 87.37 70.76 80.93 𝛼7 221-229 74.02 78.82 79.22 𝛼8 261-292 64.93 73.46 71.75 𝛽1 55-56 75.20 82.45 81.27 𝛽2 59-60 88.48 128.12 108.30 𝛽3 156-164 75.81 70.34 75.46 𝛽4 211-215 69.90 58.27 72.37 𝛽5 246-254 64.35 60.44 62.77 𝛽6 295-297 74.94 63.68 69.40 
L1 99-103 48.61 47.75 49.10 
L2 133-136 100.11 85.33 93.32 
L3 152-155 91.55 76.55 85.26 
L4 216-220 89.01 80.53 85.64 
L5 230-245 76.28 70.41 78.87 
L6 255-261 82.14 80.56 82.08 
 
